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Abstract. Background/Aim: Periprostatic adipose tissue
(PPAT) directs tumour behaviour. Microenvironment secretome
provides information related to its biology. This study was
performed to identify secreted proteins by PPAT, from both
prostate cancer and benign prostate hyperplasia (BPH)
patients. Patients and Methods: Liquid chromatography-mass
spectrometry-based proteomic analysis was performed in
PPAT-conditioned media (CM) from patients with prostate
cancer (CMs-T) (stage T3: CM-T3, stage T2: CM-T2) or
benign disease (CM-BPH). Results: The highest number and
diversity of proteins was identified in CM-T3. Locomotion was
the biological process mainly associated to CMs-T and
reproduction to CM-T3. Immune responses were enriched in
CMs-T. Extracellular matrix and structural proteins were
associated to CMs-T. CM-T3 was enriched in proteins with
catalytic activity and CM-T2 in proteins with defense/immunity
activity. Metabolism and energy pathways were enriched in
CM-T3 and those with immune system functions in CMs-T.
Transport proteins were enriched in CM-T2 and CM-BPH.
Conclusion: Proteins and pathways reported in this study could
be useful to distinguish stages of disease and may become
targets for novel therapies.
Prostate cancer (PCa) is the second most common cancer in
men worldwide. While most men have indolent disease,
which can be treated properly, the problem consists in
reliably distinguishing between indolent and aggressive
disease. Evidence shows that the microenvironment affects
tumour behavior. 
Adipose tissue microenvironment is now known to direct
tumour growth, invasion and metastases (1, 2). Adipose
tissue is adjacent to the prostate gland and the site of
invasion of PCa. Periprostatic adipose tissue (PPAT) was
present on 48% of prostatic surfaces. The distribution of
periprostatic adipose tissue varied among the different
surfaces of the prostate, with the anterior, posterior, right,
and left surfaces showing 44%, 36%, 59%, and 57% adipose
tissue, respectively (3). Recent evidence demonstrates that
adipose tissue is not only an energy storage reservoir, but
also a metabolically active organ (4) that produces
hormones, growth factors, adipokines (5) and other
molecules that not only affect physiological cellular
responses, but also contribute to paracrine and autocrine
signalling networks, especially in tumour microenvironments
where hormonal dependence mediates cancer progression (6-
11). Adipose tissue contains adipose-derived stem cells
(mesenchymal stem cells), preadipocytes and adipocytes in
different degrees of differentiation, endothelial cells,
macrophages, fibroblasts, blood vessels and inflammatory
cells that can modulate the tissue secretion pattern via
interaction with different cell types and nearby organs. There
is a two-way paracrine regulation between PCa cells and
cells that make up adipose tissue. Adipose microenvironment
is involved in signalling pathways that influence PCa
progression. Finley et al. (6) showed that PPAT is a
modulator of PCa aggressiveness through the secretion of
high local levels of IL-6. They found that IL-6 levels in
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PPAT but not in the serum were correlated with higher
Gleason score, interestingly highlighting that the
concentration of factors found in the local microenvironment
of a tumour may not reflect the levels detected in peripheral
blood. IL-6 can activate the androgen receptor and may
promote intracellular synthesis of androgens in the prostate
(12). Cytokines synthesized by fat-resident regulatory and
conventional T cells could directly affect the synthesis of
inflammatory mediators. In vitro data suggest that adipose
stem cells can increase the production of cytokines and
growth factors, thus resulting in PCa invasive growth and
metastasis (13). More recent studies have shown that PPAT
secretes factors that alter the microenvironment of the PCa,
promoting proliferation, survival or motility. Results from
our laboratory (10) showed that factors secreted by PPAT
may be influencing tumour behavior. We verified a weak
attachment of LNCaP cells (relative to control medium) to
components of PPAT from patients with PCa. Contrarily,
PC3 cells showed increased attachment to components of
PPAT from patients with PCa or benign disease. Moreover,
we found that PPAT from men with PCa produced and
released higher proMMP-9 than men with benign prostatic
hyperplasia (BPH). Also, Ribeiro et al. (13) observed that
PPAT secreted metalloproteases in PCa patients. In addition,
they found altered genes related to the cellular activity of
adipose tissue in overweight/obese subjects and a downward
impact on immunity and inflammation, mainly related to the
complement system (down-regulation of CFH). 
It is now known that interaction between PCa cells and
PPAT microenvironment is a process driving cancer
aggressiveness (14-16). Secreted proteins into the
microenvironment play a role in the regulation of both,
physiological and pathophysiological processes. Such secreted
proteins include growth factors, ECM degrading enzymes, cell
motility factors, angiogenic factors and immunoregulatory
cytokines participating in various physiological processes such
as immune defense and cell signalling. Bioactive molecules
also play critical roles in processes that include cancer
promotion, cell differentiation, invasion, metastasis and
angiogenesis by regulating cell-cell adhesion and ECM
interactions. However, there is not enough knowledge about
which proteins are secreted by PPAT both in healthy or
diseased conditions. Hence, a detailed characterization of
secreted proteins which take part in the bi-directional
heterotypic cross-talk and their critical role in cell physiology
and signalling pathways may increase understanding of the
disease and facilitate development of improved therapies.
Another point to be considered is the fact that regional
differences in the production of proteins from fatty deposits
have been documented. Regarding the study of PPAT coming
from patients with BPH (B-PPAT), it is interesting not only to
compare it with PPAT coming from patients with tumours (T-
PPAT), but also to determine the secretome from such a
benign pathology, due to the impossibility of obtaining PPAT
samples from healthy subjects. 
Several studies performed secretome analysis of separate
adipose tissue-derived cell types but, they did not reflect the
secretome of adipose tissue as a whole, considering the
crosstalk between different cell types from within the same
adipose tissue (17). Furthermore, it is now known that adipose
tissue composition and secretome differ depending on the
location in the body and on the disease stage, as in cancer (17). 
Herein, we propose to identify secreted proteins by PPAT
from, both PCa (T3 and T2 stage) and benign prostate
hyperplasia (BPH) patients, using liquid chromatography and
mass spectrometry analysis with the Orbitrap technology. For
this purpose, conditioned medium was collected from PPAT
explants of human samples and, then a bioinformatics
analysis was carried out.
Patients and Methods 
Ethics statement and tissue procurement. Human PPAT was obtained
from 15 patients. Ten patients were undergoing radical prostatectomy
for prostate tumours. Of these, five were at T3 stage (PPAT-T3, age
range=57-70 years, BMI range 37.0-26.1 kg/m2) and five were at T2
stage (PPAT-T2, age range=57-66 years). Five patients were
undergoing adenomectomy for BPH (PPAT-B, age range=68-71
years, BMI range=21.9-30.2 kg/m2). None of the patients received
preoperative therapy. All patients gave their written consent for this
research and the corresponding ethics committee from both the
hospital and IBYME approved the procedures. In every case, once
the anterior surface of the prostate had been surgically exposed, the
fat tissue surrounding the superficial venous plexus of Santorini was
dissected. A fatty, loose tissue surrounds this plexus on both sides of
the inferior portion of the anterior surface of the prostate and,
approximately, 0.5-2 g of this fat tissue was separated for further
processing. Clinical and pathological characteristics of the specimens
used (pTNM, Gleason score, age and BMI) are shown in Table I. All
BPH specimens showed histological epithelial and/or stromal cell
hyperplasia but no malignant cells. 
Conditioned media from PPAT. PPAT explants were processed under
sterile conditions within 2 h after surgery. Tissue was transferred to
a centrifuge tube and carefully washed three times with 45 ml ice-
cold phosphate buffer saline solution (PBS) and supplemented with
gentamicin (GIBCO, NY, USA) (50 μg/ml). Washed tissue was
transferred to a centrifuge tube containing 35 ml PBS at 37˚C and
centrifuged at 277 × g at RT to remove red blood cells. Whole tissue
was then weighed. Tissue was then placed in a culture flask with
M199 culture medium (Sigma, St. Louis, MO, USA) (normalizing
1 g tissue/10 ml M199), supplemented with gentamicin (50 μg/ml)
and incubated at 37˚C in 5% CO2. After 1 h, medium was replaced
with fresh medium and incubated for another 24 h. The resulting
conditioned medium (PPAT-CM) was collected, centrifuged, filtered
and stored at –80˚C until use (18). M199 incubated in the same
conditions was used as control medium. After its collection, in
addition to secreted proteins, conditioned medium may also contain
shed membrane proteins and secretory vesicles (e.g. microvesicles,
exosomes, and membrane particles). Both, centrifugation of the
medium after collection and filtration (used for removal of non-
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adherent cells and debris) will leave the secretory vesicles in the
medium (together with Golgi membranes). Thus, secretory vesicle
proteins can be released into the conditioned medium during
processing and they can constitute a fraction of the secretome (19).
Collection of conditioned media for analysis. For secretome analysis
equal volume of PPAT-CM was collected from each patient and
separated into three groups: a) patients with PCa stage T3 (CM-T3;
n=5); b) patients with PCa stage T2 (CM-T2; n=5) and c) group of
CMs derived from patients with BPH (CM-BPH; n=5). The amount
of proteins in the CMs was quantified using Nanodrop 2000
(Thermo Scientific, Waltham, MA, USA). Control medium was
used as blank.
Liquid chromatography and mass spectrometry analysis. Protein
digestion and Mass Spectrometry analysis were performed at the
Proteomics Core Facility CEQUIBIEM, at the University of Buenos
Aires/CONICET (National Research Council) as follows: protein
samples were treated with dithiotreitol (DTT) in 50 mM ammonium
bicarbonate at a final concentration of 10 mM (45 min, 56˚C) and
alkylated with iodoacetamide in the same solvent at a final
concentration of 20 mM (40 min, RT, in darkness). This protein
solution was precipitated with 1/5 volume of trichloroacetic acid
(TCA) at –20˚C for at least 2 h and, then, centrifuged at maximum
speed for 10 min (4˚C). The pellet was washed twice with ice-cooled
acetone and dried at RT. Proteins were resuspended in 50 mM
ammonium bicarbonate, pH=8 and digested with trypsin (Promega
V5111, Madison, WI, USA). Then, the peptides were purified and
desalted with ZipTip C18 columns (Millipore, MA, USA). The
digests were analyzed by nanoLC-MS/MS in a Thermo Scientific
QExactive Mass Spectrometer coupled to a nanoHPLC EASY-nLC
1000 (Thermo Scientific). For the LC-MS/MS analysis,
approximately 1 μg of peptides was loaded onto the column and
eluted for 120 min using a reverse phase column (C18, 2 μm, 100 A,
50 μm × 150 mm) Easy-Spray Column PepMap RSLC (P/N ES801)
suitable for separating protein complexes with a high degree of
resolution. Solvent A was 0.1% formic acid in water whereas B was
0.1% formic acid in acetonitrile. The flow rate used for the nano
column was 300 nl min-1 and the solvent ranged from 7% B (5 min)
to 35% (120 min). The injection volume was 2 μl. The MS equipment
has a high collision dissociation cell (HCD) for fragmentation and an
Orbitrap analyzer (Thermo Scientific, Q-Exactive). A voltage of 3.5
kV was used for Electro Spray Ionization (Thermo Scientific, EASY-
SPRAY). XCalibur 3.0.63 (Thermo Scientific) software was used for
data acquisition and the equipment configuration allowed peptide
identification along with chromatographic separation. Full-scan mass
spectra were acquired in the Orbitrap analyzer. The scanned mass
range was 400-1800 m/z, at a resolution of 70,000 at 400 m/z and the
twelve most intense ions in each cycle, were sequentially isolated,
fragmented by HCD and measured in the Orbitrap analyzer. Peptides
with a charge of +1 or with unassigned charge state were excluded
from fragmentation for MS2.
Analysis of MS data. Q Exactive raw data were processed using
Proteome Discoverer software (version 2.1.1.21 Thermo Scientific)
and searched against Homo sapiens protein sequences database with
trypsin specificity and a maximum of one missed cleavage per
peptide. Carbamidomethylation of cysteine residues was set as a fixed
modification and oxidation of methionine was set as a variable
modification. Proteome Discoverer searches were performed with a
precursor mass tolerance of 10 ppm and product ion tolerance of 
0.05 Da. Static modifications were set to carbamidomethylation of
Cys, and dynamic modifications were set to oxidation of Met and 
N-terminal acetylation. Protein hits were filtered for high confidence
peptide matches with a maximum protein and peptide false discovery
rate of 1% calculated by employing a reverse database strategy. 
Protein categorization. To understand the role of identified proteins
in cell biology, they were integrated and interpreted through several
bioinformatics tools. Proteins detected in secretome of PPAT-CMs
were classified based on the PANTHER system (Protein ANalysis
THrough Evolutionary Relationships) (www.pantherdb.org/)
(Version 13.1, released 2018-02-03). It is a resource that classifies
genes and proteins based on their reported biological processes,
molecular functions, cellular components, protein classes and
pathways. Furthermore, FunRich was used (http://www.funrich.org/)
(Functional Enrichment analysis tool) mainly for enrichment test
which has been performed against Homo Sapiens background (20).
Also, CM proteins were subjected to in silico analysis using
ProteINSIDE tool (http://www.proteinside.org) (21) (workflow
version 1.2/last update 13-Mar-2017) to predict classic secretion of
proteins (endoplasmic reticulum/Golgi apparatus dependent
pathway) through the SignalP tool (version 4.1]) and to identify
proteins that are putatively secreted by non-classical protein exports
or ER/Golgi-independent protein secretions. ProteINSIDE checks
the sub-cellular localazation of proteins and compares their
annotation relatively to the list of GO terms related to secretion.
Lastly, to support these predictions (classical and non-classical
ways) ProteINSIDE runs the TargetP software (22) that predicts the
subcellular localazation of proteins using the amino acid sequence.
The double query of protein secretion both by the peptide signal
prediction from protein sequence and the GO annotation is unique
to ProteINSIDE (21). SignalP (discrimination score) discriminates
signal peptides from non-signal peptides (0 to 1 where 1 is the best)
and TargetP score (reliability class) from 1 to 5, where 1 indicates
the strongest prediction. 
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Table I. Clinical and pathological characteristics of patients.
Pathology            Pathologic stage            n              Gleason score             Age (years)                p-Value                BMI (kg/m2)                   p-Value
BPH                                                            5                                                     68.4±1.7                                                   25.3±3.5                             
PCa                             pT2b-c                    5                        ≤7                         65.4±4.3                                                   26.7±3.2                             
                                    pT3a                      5                        ≤7                         62.6±5.1                     0.166                      29.4±5.0                         0.372
Data was presented like a media±standard deviation: differences between groups were calculated using the t-test. BPH: Benign prostate hyperplasia;
PCa: prostate cancer.
Overrepresentation test has been performed against Homo
sapiens background using functional annotation data set provided
in Panther. The exponentially modified protein abundance index
(emPAI) (23) was used for protein abundance comparison.
Statistical methods. Statistical analysis was performed using
GraphPad Prism software (La Jolla, CA, USA). T-test was used for
testing clinico-pathological data and ANNOVA with Dunn’s post
test for protein quantification. Benjamini and Hochberg (BH) false
discovery rate method was taken into consideration in enrichment
data analysis for p- corrected value. p-Values less than 0.05 were
considered statistically significant.
Results 
No significant differences were found in age or body mass
index (BMI) between PCa and BPH patients. However,
patients with advanced cancer had a higher average body
mass index compared to patients with benign pathology. The
amount of proteins was 22.5±1.7 μg/ml, 34.5±6.4 μg/ml and
7.3±1.3 μg/ml in CM-T3, CM-T2 and CM-BPH, respectively
PPAT-CM derived from patients with tumour (CMs-T)
contained higher amount of proteins relative to CM-BPH.
There were no significant differences in the amount of
proteins between CMs-T, but there was a significant
difference in the amount of proteins between CM-T2 and
CM-BPH (p<0.05). A total of 574 PPAT proteins were
identified by MS approach. The molecular weight (MW) of
the proteins detected in this study ranged from 628.7 kDa
(neuroblast differentiation-associated protein AHNAK) to 3.6
kDa (proteasome subunit alpha type-2 (PSMA2, fragment).
The number of proteins distributed between the three groups
of CMs, according to their MWs, is shown in Figure 1A.
Most of the detected proteins have a MW between 10 and 30
kDa and nearly 50% of them were below 40 kDa, while 80%
of the total proteins had a MW below 70 kDa. Proteins in the
range of 100 to 199 kDa were also detected in CM-T3 and
CM-BPH, while proteins from CM-T2 had MW in the range
of 200 to 299 kDa. Using this proteomic approach, it was
possible to detect several proteins below 10 kDa and above
200 kDa, a range that is outside the separation limits of
conventional two-dimensional gel electrophoresis.
To know which proteins are specific or overlap within the
three groups of CMs, the protein accession numbers from each
CM were introduced in a three-way Venn diagram tool (Figure
1B). The highest number of identified proteins corresponded
to CMs-T. Patients in T3 stage had the highest number of
identified proteins (563), followed by CM-T2 (78 proteins)
and patients with benign disease (52 proteins). The number of
specific proteins in the three groups was 477 of which 467
(81.4%) were specific for CM-T3. Probably, this group of
proteins might contain bioactive molecules contributing to
progression of PCa. Nine proteins (1.6%) were specific for
CM-T2 and only one protein (0.2%) was specific for CM-
BPH. The CMs-T shared 46 proteins (8%), while 28 proteins
(4.9%) were common in CM-T3 and CM-BPH, and one
protein (0.2%) was common in CM-T2 and CM-BPH. The
three groups of CMs shared 22 proteins (3.8%). Table II
shows a list of the identified genes that arised from this
analysis. Two uncharacterized proteins were detected in CM-
T3 with MW of 8.3 and 40.4 kDa, respectively. 
Proteins expressed by adipose tissue were detected in the
three CMs. Among them, adipocyte fatty acid-binding
protein (FABP4, involved in lipid transport), isoform 2 of
CANCER GENOMICS & PROTEOMICS 16: 29-58 (2019)
32
Figure 1. Distribution of proteins detected in conditioned media of periprostatic adipose tissue according to their molecular weights (MW) as
obtained from MS analysis (A). Venn diagram depicting the number of specific and common proteins (B). 
perilipin-4 (PLIN4, whose major role is in lipid droplet
formation) and haptoglobin (HP), were released by explants
of human visceral and subcutaneous adipose tissue (24).
Also, as expected, proteins secreted during human
adipogenesis were detected in the three CMs. Some of them
were: isoform 2 of Collagen alpha-3(VI) chain (COL6A3)
and alcohol dehydrogenase 1B (ADH1B, plays a major role
in ethanol catabolism), filamin-A (FLNA), glucose-6-
phosphate isomerase (GPI), galectin-1 (LGALS1), prelamin-
A/C (LMNA), serotransferrin (TF), thrombospondin-1
(THF), isoform 2 of Tropomyosin alpha-4 (TPM4), alpha-
2-macroglobulin (A2M) and vimentin (VIM) (25).
The unique protein detected in CM-BPH that was not
shared between CMs-T was heterogeneous nuclear
ribonucleoprotein D0 (HNRNPD/AUF1, a transcriptional
regulator). Recent findings show that hnRNP proteins are
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Table II. Gene name (GN) of specific or shared proteins identified by MS in the conditioned media from periprostatic adipose tissue.
CM                                         Gene name
BPH, T2 and T3                    A2M ADH1B APOA1 COL14A1 COL6A3 DDAH2 FABP4 FLNA GPI HBA1 HIST1H4A HP IGKV1D-33 
                                              LGALS1 LMNA MYH7 PLIN4 SERPINA1 TF THBS1 THBS1 TPM4 VIM
BPH and T2                          APOA2
BPH and T3                          A1BG ACTN1 ACTN4 AHNAK ANXA2 APOA4 COL15A1 CYB5A CYB5A FGA FGB FN1 HPX HSPE1 
                                              IGHG3 IGKC IGLC2 JUP PGM1 PRDX1 RNH1 RSU1 S100A9 
                                              SERPINE1 TAGLN2 TKT TPM1 TPM3 TUBA1A
T2 and T3                              ACTB AKR1C3 ALDH1A1 ALDH2 ANK1 ANXA1 APOH BCAM BCAP31 C4A CD248 DES EHD2 EPB41L3
                                              FGG HBD HIST1H2BK HRNR IGHA1 IGHA2 IGHM IGLV3-21 IGKV3-20 IGHM KNG1 LAMB2 LRG1 
                                              MSN OLFML1 ORM1 ORM2 PLEC PSMA1 PSMB4 PTX3 SERPINC1 SOD3 SORBS1 SPTA1 SPTAN1 
                                              SPTBN1 TLN1 TNXB TPI1 VCL YWHAG
BPH                                       HNRNPD
T2                                          AHSG ANXA6 F12 HNRNPA2B1 IGHV4-34 IGHV3-33 LPP NSFL1C SORBS2 
T3                                          ABCE1 ABI3BP ACO1 ACSL1 ACTR2 ACTR3 ACYP2 ADAMTS4 ADIRF ADM2 AFM AGXT2L2 AHCY 
                                              AHSP AKAP12 AKAP9 ALAD ALDH1L1 ALDOA ALPK3 AMBP ANKRD50 ANXA5 AOC3 APCS APMAP 
                                              APOA1BP APOB APOC3 APOD APOE ARHGDIA ARHGDIB ARPC5 ARSA ASAP1 ATG13 ATP2B4 ATP5A1 
                                              AZGP1 AZU1 B2M BANF1 BLM BLMH BLVRB BMP3 BRCA2 C19orf10 C1QB C1QC C1S C3 C4BPA C5 
                                              C9 CA1 CA2 CAB39L CALB2 CALD1 CALM1 CALR CAP1 CAPG CAPN1 CAPN10 CAPZA2 CAT CAV1 
                                              CCT3 CCT8 CD109 CD163 CD34 CD36 CD55 CDH13 CDH5 CEP89 CES1 CFB CFD CFH CFHR1 CFL1 CHI3L1
                                              CILP CLCC1 CLCN1 CLEC3B CLTC CLU CMA1 CNN1 CNP COL12A1 COL18A1 COL1A1 COL1A2 COL6A1 
                                              COL6A2 COQ10A CP CPA3 CPM CRTAC1 CRYAB CRYZ CSPG4 CSRNP2 CSRP1 CSTB CXCL1 CXCL2 CYCS
                                              DAG1 DBI DCN DDB1 DDT DHDDS DHX33 DKFZp586F0420 DMD DNAJA1 DNAJB2 DNAJB6 DNMBP 
                                              DNPEP DPYSL2 DSP DSTN DYNLRB2 ECH1 ECHDC1 ECI1 ECM1 EEA1 EEF1A1 EEF2 EHD1 EIF4G1 ELANE
                                              ELAVL1 EMILIN1 ENO1 EPHX1 ERLIN1 ESYT1 F13A1 F2 FABP5 FAH FAM122A FBLN1 FBN1 FERMT2 
                                              FHL1 FKBP1A FKBP2 FLNB FLNC FTH1 FTL GALNT5 GAPDH GC GDI1 GLO1 GLOD4 GLRX GNB1 GNPDA2
                                              GOT1 GPD1 GPR124 GPX3 GSDMA GSN GSTM2 GSTP1 GYG1 H2AFY H7C469 HBG1 HK1 HNRNPA1
                                              HNRNPC HPCAL1 HPRT1 HRG HRSP12 HSP90AA1 HSPA1A HSPA4 HSPA5 HSPA8 HSPB1 HSPG2 IDH1 
                                              IGF2BP1 IGHG1 IGHG2 IGHG4 IGHV1-2 IGHV3-53 IGHV3-23 IGHV3-7 IGKV1-5 IGKV1D-12 IGKV4-1 IGLL5 
                                              IGLL5 IL6 IGLV3-25 IGLV6-57 ILF3 IMMT INF2 INSM2 IQGAP1 IRS2 ITIH1 ITIH2 ITIH4 ITIH5 ITSN1 J3QL48
                                              KCTD12 KDM5C KPRP KTN1 LAMA2 LAMA4 LAMA5 LAMB1 LAMC1 LAP3 LASP1 LCN2 LCP1 LDHA LDHB 
                                              LGALS3 LGALS3BP LHPP LMNB1 LMNB2 LOC644656 LPO LRP1 LTA4H LTBP1 LTBP2 LTF LUM LYZ MAP4 
                                              MATN2 MCAM MDH1 MDH2 ME1 MFAP4 MGLL MLEC MMP8 MMP9 MPO MYEOV2 MYH10 MYH11 MYH2 
                                              MYH9 MYL1 MYL12A MYL6 MYO1 MYO18B MYO1C MYOC NCAM1 NCL NDFIP2 NEDD8 NID1 NID2 
                                              NLRP7 NME1 NPEPPS NPM1 NRP1 NSF NSL1 NUDT5 ODF3L2 OGN OTOGL P4HB PALM PALM2 PARK7 
                                              PARVA PCLO PCOLCE PDIA3 PDIA6 PDLIM7 PEBP1 PECAM1 PF4 PFN1 PGAM1 PGD PGK1 PGM5 PHLDB1
                                              PITHD1 PIWIL1 PKIA PKM PLEK PLG PLIN1 PLS3 PNP POSTN PPIA PPIB PPP1CC PPP2R4 PRDX2 PRDX3 
                                              PRDX4 PRDX5 PRDX6 PRELP PRKACB PRKAR2A PRKCDBP PRKCSH PROS1 PSMA2 PSMA3 PSMA4 PSMA5
                                              PSMA6 PSMA7 PSMB1 PSMB5 PSMC6 PSMD9 PTBP1 PTPLAD1 PTPN11 PTPRG PTPRS PTPRT PTRF PURA 
                                              PXDN PYCARD PYGL QDPR RAB7A RAD23B RBBP5 RBM5 RBMX RNASE2 ROR2 RPLP1 RPS28 RRBP1 
                                              RRBP1 RTN4 S100A10 S100A8 S100B SCP2 SELENBP1 SEP11 SERPINA3 SERPINA4 SERPINB12 SERPINB4 
                                              SERPINB6 SERPIND1 SERPINF1 SERPINF2 SERPING1 SETD9 SF3A1 SH3BGRL SH3BGRL2 SH3BGRL3 
                                              SIRPB1 SIRPB2 SLC2A1 SLC2A14 SLC4A1 SLC9A3R2 SLMAP SNRPN SOD1 SOS1 SP140L SPARC SPHK2
                                              SPON1 SPTB SRGN SSX2 STX7 SYNPO SYTL5 TAB3 TAGLN TALDO1 TAOK1 TRAS TCP1 TGFBI TGM2 
                                              TIAF1 TIMP1 TLN2 TMPO TNC TNS1 TPSAB1 TPT1 TROVE2 TTC40 TTR TWF2 TXN TXNRD1 UBB UBE2L3
                                              UBE2N UBE2V2 UBR7 UGGT1 UGP2 ULK4 USO1 UTRN VAPB VASP VCAN VCP VPS26A VTN VWF WARS 
                                              WDR1 WDR49 XRCC6 YWHAZ ZBTB48 ZFHX3
crucial factors implicated in maintenance of stem cell self-
renewal, pluripotency and cell differentiation (26). Previous
studies on secretory proteomes detected this protein in
human adipose stromal vascular fraction (coming from
subcutaneous adipose tissue obtained during elective
surgery) (27) and also during adipogenesis of preadipocytes
coming from subcutaneous fat tissue (females undergoing
panniculectomy surgery) (25). 
Proteins exclusively detected in CM-T2 were: alpha-2-HS-
glycoprotein/fetuin-A (AHSG), annexin (ANXA6), coagulation
factor XII (F12), isoform A2 of heterogeneous nuclear
ribonucleoproteins A2/B1 (HNRNPA2B1), lipoma-preferred
partner (LPP), isoform 4 of NSFL1 cofactor p47 (NSFL1C),
isoform 9 of Sorbin and SH3 domain-containing protein 2
(SORBS2), Ig heavy chain V-I region V35 (IGHV4-34) and Ig
heavy chain V-III region KOL (IGHV3-33). Recent works
identified the presence of AHSG in the secretome of rat white
adipose tissue. Visceral adipose tissue expresses and secretes
AHSG, however, its secretion pattern and function are poorly
understood (28). In an animal model of obesity, AHSG induced
inflammation in adipocytes by deregulating energy sensors
(29). AHSG has been implicated in diverse normal and
pathological processes including vascular calcification and
bone metabolism regulation, insulin resistance, protease
activity control, keratinocyte migration and breast tumour cell
proliferative signalling (30). It is a major serum cell attachment
factor particularly for tumour cells (31). In the presence of
fetuin-A, detached tumour cells (like breast and colorectal)
secreted exosomes which contained, in addition to other
exosomal proteins, fetuin-A and histones. These exosomes
mediated adhesion and cell spreading (32). Annexin-2
(ANXA2) (not detected in CM-T2) and annexin-6 (ANXA6)
were required in fetuin-A mediated cell adhesion (32).
AHSG/fetuin-A is an established tumour antigen in several
types of cancer, including breast, glioblastoma, and pancreas
cancer and was detected in serum samples from patients with
a diagnosis of early-stage breast cancer (33). Serum
autoantibodies reactive to fetuin, showed utility as a prognostic
indicator for PCa patients at risk of progressing to metastatic
disease (34). In adipocytes, annexin (ANXA6) protein
expression was up-regulated by high fat diet as well as
oxidative stress (35). With respect to their relationship with
cancer, low levels of ANXA6 expression were detected in
localized PCa and were reduced during progression of the
disease (36). ANXA6, identified in exosomes derived from
human mesothelioma cells (37, 38), regulates membrane-
cytoskeleton dynamics and membrane-fusion events between
intracellular compartments and plays a role in the inward
vesiculation process (39). Another detected protein was isoform
A2 of heterogeneous nuclear ribonucleoproteins A2/B1
(HNRNPA2B1) which is an RNA-binding protein reported to
be up-regulated in cancer. Its overexpression mediates
unregulated proliferation of PCa cells and a trend towards
overexpression was also reported for nuclear hnRNPA2 protein
in PCa as compared with BPH. Cytoplasmic hNRNPA2 was
found in aggressive cancer. Although its function has not been
characterized, this protein may affect the cancer cell phenotype
through 3’-UTR mRNA-mediated regulation of β-catenin
expression and other cancer-relevant genes (40). Exosomes
contain specific repertoires of mRNAs, microRNAs (miRNAs)
and other non-coding RNAs that can be functionally
transferred to recipient cells. HNRNPA2/B1 is a key player in
the sorting of miRNA in exosomes and provides potential tools
for the packaging of selected regulatory RNAs in exosomes,
which are of interest in biomedical applications (41). No
reports were found about this protein in relation to adipose
tissue. Lipoma-preferred partner (LPP) is a member of the
zyxin family of LIM proteins that has been characterized as a
promoter of mesenchymal/fibroblast cell migration. More
recently, it has emerged as a critical inducer of tumour cell
migration, invasion and metastasis. LPP contributes to
malignant phenotype by its ability to shuttle into the nucleus,
localize to adhesions and, most recently, to promote
invadopodia formation (42). However, it has been determined
that in breast cancer, invadopodia formation, cell extravasation
and metastasis require an intact LPP LIM domain and the
ability of LPP to interact with α-actinin (43). Another protein
detected in CM-T2 was isoform 9 of Sorbin and SH3 domain-
containing protein 2 (SORBS2). It is an adipose tissue depot-
specific gene; more methylated and less expressed in
subcutaneous adipose tissue than in omental visceral adipose
tissue (OVAT) in both non-obese and obese subjects and a
strong association of SORBS2 methylation with BMI was
found in OVAT (44). 
Only one overlapping protein was found between CM-T2
and CM-BPH: apolipoprotein A-II (APOA2). It is a cargo
protein, predicted secreted, associated with lipoprotein
metabolism and general inflammation. It was recently detected
in the secretome of breast cancer-associated adipose tissue (17).
Interestingly, ApoA-II was reported overexpressed in serum of
individuals with PCa who have normal prostate-specific
antigen (0-4.0 ng/ml), suggesting a potential utility as a marker
in identifying indolent disease (45). Likewise, APOA2
appeared to be down-regulated in patients with PCa (stage I or
II) when compared to those with BPH in 2DE protein profiles
of serum samples (46). All these data suggest that APOA2
deserves an in-depth study to determine the usefulness of this
protein in distinguishing prostatic pathologies.
Among the 46 proteins detected in both CMT-3 and CM-T2
were proteins of the spectrin family (SPTA1, SPTAN1,
SPTBN1). Spectrins contribute to cell adhesion and migration,
interact with structural and regulatory proteins and are involved
in the regulation of DNA repair. Deregulation of spectrins,
particularly SPTAN1, seriously affects cellular behavior and
promotes tumour progression (47). Spectrin alpha chain, non-
erythrocytic 1 (SPTAN1), spectrin beta chain, non-erythrocytic
CANCER GENOMICS & PROTEOMICS 16: 29-58 (2019)
34
1 (SPTBN1) and two alpha-1-acid glycoprotein (ORM1 and
ORM2, acute phase proteins) were also detected in breast
cancer-associated adipose secretome (17). Another protein
detected in CMs-T was galectin-3 (LGALS3). It has been
reported that galectin-3, a proteolytic substrate for prostate-
specific antigen, binds to several ligands in human prostasomes,
such as ORM1 (48). Also, proteins involved in focal adhesion
like actin cytoplasmic 1 (ACTB), moesin (MSN), annexin A1
(ANXA1), isoform 1 of vinculin (VCL), talin-1 (TLN1), cell
movement (VCL, TLN1, MSN, ACTB) and invadopodium
(MSN), were detected. Extracellular superoxide dismutase [Cu-
Zn] (SOD3) that protects the extracellular matrix from
degradation by reactive oxygen species was also found in CMs-
T. Proteins involved in immune response were also detected in
the CMs-T (IGLV3-21, IGKV3-20, IGHA1, IGHA2).
Table III shows a list of the top ten proteins detected in
each CM. The top ten proteins exclusively detected in CM-
T3, were isoform 4 of myosin-11 (MYH11) and myosin-9
(MYH-9). SPATN1 was detected as one of the top ten
proteins in both CM-T2 and CM-T3. The top ten proteins
found in the list of CM-T2 (but also detected in CM-T3),
were laminin subunit beta-2 (LAMB2), talin-1 (TLN1),
hornerin (HNRN) and hemoglobin subunit delta (HBD). The
top ten proteins of CM-BPH were shared by CM-T3 and/or
CMT2. CM-T3 proteins were involved in angiogenesis, cell
adhesion and cell shape (FN1, MHY9), cellular reshaping,
movement and transport (MHY11). Cell-cell and cell-matrix
adhesion (LAMB2), cellular and protein metabolic processes
(HRNR), cellular morphogenesis (TLN1) and transport (TF
and HBD) proteins were associated to CM-T2. CM-T3 and
CM-T2 sharied proteins associated with cellular processes
(FLNA, SPTAN1) and cellular morphogenesis like vimentin
(VIM). Metabolic processes (alcohol dehydrogenase 1B
(ADH1B); transketolase, (TKT); apolipoprotein A-I
(APOA1) and isoform 2 of tropomyosin alpha-4 chain
(TPM4)), cell adhesion (isoform 2 of collagen alpha-3(VI)
chain (COL6A3)) and cellular morphogenesis (tropomyosin
1 alpha (TPM1)) proteins were associated with CM-BPH.
Functional protein classification. A UniProt search was
performed to obtain information about the two uncharacterized
proteins detected in CM-T3. One of them has aspartic-type
endopeptidase activity and in the biological process category
corresponds to autophagy, protein catabolism and proteolysis.
The other one has threonine–type endopeptidase activity and
the biological process category showed that is involved in
immune system processes and proteolysis.
A first general analysis was carried out to classify and
identify the functions corresponding to the proteins from
each PPAT-CM using PANTHER classification system. CM-
T3 proteins were categorized in 8 molecular functions, 12
biological processes, 8 cellular components, 23 protein
classes (Figure 2A, B, C, D). CM-T2 proteins were
categorized in 6 molecular functions, 11 biological
processes, 7 cellular components, 17 protein classes. CM-
BPH included 6 molecular functions, 10 biological
processes, 7 cellular components, and 15 protein classes
(Figure 2A, B, C, D). The GO analysis of proteins present
in each CM, without considering protein abundance, showed
certain grade of similarity, except for the protein class, which
showed more diversity in CM-T3 relative to CM-T2 and
CM-BPH. These results are related to the fact that PPAT
samples come all from, adipose tissue. 
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Table III. Top ten proteins detected in conditioned media from
periprostatic adipose tissue sorted according to their score.
CM-T3                                                                                          
Protein name                                                                              GN
Isoform 10 of Fibronectin                                                        FN1
Isoform 2 of Filamin-A                                                          FLNA
Fatty acid-binding protein, adipocyte                                   FABP4
Hemoglobin subunit alpha                                                     HBA1
Isoform 4 of Myosin-11                                                        MYH11
Neuroblast differentiation-associated protein                      AHNAK
Spectrin alpha chain, non-erythrocytic 1                             SPTAN1
Myosin-9                                                                                 MYH9
Alpha-2-macroglobulin                                                            A2M
Vimentin                                                                                   VIM
CM-T2
Protein name                                                                              GN
                                                                                                      
Spectrin alpha chain, non-erythrocytic 1                             SPTAN1
Hemoglobin subunit alpha                                                     HBA1
Isoform 2 of Filamin-A                                                          FLNA
Laminin subunit beta-2                                                         LAMB2
Talin-1                                                                                      TLN1
Serotransferrin                                                                            TF
Vimentin                                                                                   VIM
Haptoglobin (Fragment)                                                            HP
Hornerin                                                                                  HRNR
Hemoglobin subunit delta                                                       HBD
CM-BPH                                                                                       
Protein name                                                                              GN
Alcohol dehydrogenase 1B                                                   ADH1B
Fatty acid-binding protein, adipocyte                                   FABP4
Isoform 2 of Collagen alpha-3(VI) chain                           COL6A3 
Neuroblast differentiation-associated protein                      AHNAK
Alpha-2-macroglobulin                                                            A2M
Transketolase                                                                            TKT
Hemoglobin subunit alpha                                                     HBA1
Apolipoprotein A-I                                                                APOA1
Isoform 2 of Tropomyosin alpha-4 chain                              TPM4 
Tropomyosin 1 (Alpha), isoform CRA_f                              TPM1 
Catalytic activity, binding activity, structural molecule
activity, receptor activity, transporter activity and antioxidant
activity were common molecular functions reported for CMs
proteins (Figure 2A). Binding activity was the main
molecular function (Figure 2A) while cellular and metabolic
were the main processes found in the category of biological
process for all CMs (Figure 2B). Locomotion was a
biological process associated with CM-T3 and CM-T2, while
reproduction was associated to CM-T3 proteins (Figure 2B).
Cell part was the main cellular component associated with
CMs-T while macromolecular complex and extracellular
region were for CM-BPH (Figure 2C). In terms of protein
class, several annotations were specific to CM-T3 secretome,
among them: cell junction proteins, ligases, lyases, storage
proteins and transferases (Figure 2D). Extracellular matrix
(ECM) and structural protein were associated to CMs-T
while transcription factors were associated to CM-T3 and
CM-BPH proteins. ECM composition and remodeling are
crucial for tumourigenesis and metastatic progression of
cancer. Some of ECM proteins identified in CM-T3 were
basement membrane-specific heparan sulfate proteoglycan
core protein (HSPG2, linker protein), laminins (LAMA5,
LAMA2, LAMB1 and LAMC1, linker proteins, protease
inhibitor), latent-transforming growth factor beta-binding
protein 1 (LTBP1, cell adhesion glycoprotein), EMILIN-1
(glycoprotein), fibrilin-1 (FBN1, cell adhesion glycoprotein),
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Figure 2. Protein categorization using the PANTHER classification system and annotated with ontology terms (GO). (A) Molecular functions, (B)
Biological processes, (C) Cellular components, (D) Protein classes.
and spondin-1 (SPON1, glycoprotein). Laminin subunit beta-
2 (LAMB2) was detected in CMs-T. 
In tumours that invade adjacent adipose tissue like ovarian
cancer, up-regulation of genes encoding for fatty acid
transport proteins, such as FABP4 and platelet glycoprotein
4 (CD36), as well as angiogenic genes like hematopoietic
progenitor cell antigen CD34 (CD34) (49), was shown.
Interestingly, these proteins were also detected in our adipose
secretome. Adipocyte-derived FABPs are involved in cancer
initiation and progression promoting homing, migration and
invasion (50); FABP4 was detected in the three CMs and it
was one of the top ten proteins in CM-T3; platelet
glycoprotein 4 (CD36) and hematopoietic progenitor cell
antigen (CD34) were detected only in CM-T3. Also, it was
possible to detect epidermal fatty acid-binding protein
(FABP5). FABP4 and FABP5 are expressed in macrophages
and endothelial cells which are important contributors to
adipose tissue and tumour microenvironment (51, 52).
FABP4 has also an important role in adipocyte-mediated
transport of lipids to prostate tumour cells as energy source
for bone metastasis (53). FABP4 was found to be highly
overexpressed in prostate skeletal tumours from obese mice
and in bone metastasis samples from PCa patients, thus
showing the importance of lipid trafficking in tumour
metastasis and implicating FABP4 as a mediator of
adipocyte-tumour cell interactions within the metastatic
niche (53). Secretion of FABP4 responds to signals that
induce lipolysis; this could be related to peritumoural
adipose tissue and cancer associated adipoctyes (CAA),
where lipolysis is enhanced and FABP4 could be released
and have a paracrine action in tumoural tissue (50, 54). It is
known that healthy life style lowers the risk of aggressive
PCa. Lazaro et al. (55) observed that increasing aerobic
physical activity decreased FABP4 plasma levels,
independently of weight reduction, which would have a
direct impact on cancer progression. FABP5 is involved in
the uptake and transport of long chain fatty acids and plays
a key role in cell signalling, gene regulation, cell growth and
differentiation (56). The levels of circulating FABP5 in
cancer are still unknown. FABP5 was found increased in
PCa samples (57, 58) and its inhibition could inhibit
tumourigenesis probably by reducing the expression of
VEGF (57). These studies show that FABP4 and FABP5
could be useful as clinical markers and may prove a viable
target to attack adipose tissue-related cancers. 
Proteins related to cellular movement and migration were
also detected. LGALS1, COL14A1 (detected in the three
CMs), LAGLS3 and LGALS3BP (detected in CM-T3) are
involved in the modulation of cell-cell and cell-matrix
interactions and play a role in cancer-stroma interactions
during the process of PCa metastasis (59). Vimentin (VIM)
was within the top ten detected proteins in CMs-T. VIM was
reported present in mesenchymal cells and related to
adipocyte cell shape during adipogenesis contributing to both
the formation of lipid droplets and the regulation of fatty
acid transport through an interaction with FABP4 (21). Thus,
VIM has a role in early and late stages of adipogenesis. 
The detection of complement factors agrees with the
emerging evidence that adipose tissue and adipocytes are a
source of complement components, which have been proposed
to be important in tissue maintenance and apoptosis (60, 61).
Also, enrichment in complement genes was noted during
adipocyte differentiation (62). Similarly, we observed eight
complement genes in the secretome of CMs-T. Particularly, in
CM-T3 C1QB, C1QC, C1S, C3, C5, C9 were detected and in
CMs-T, C4A was also detected. The role of complement
proteins in cancer growth is still unknown, but they are likely
related to dysregulation of mitogenic signalling pathways,
constant cellular proliferation, angiogenesis, resistance to
apoptosis, and escape from the immune system (63). 
PANTHER pathways analysis gave additional information.
As expected, more pathways are associated with the secretomes
of CMs-T (CM-T3: 67 pathways and CM-T2: 21 pathways)
than CM-BPH (15 pathways). Table IV shows a list of
pathways that involved at least 4 genes. Secreted proteins can
act as ligands that engage specific receptors on the same cell,
nearby cells, or distant cells and induce specific pathways.
Proteins and pathways that are distinct or dysregulated in CMs-
T or in CM-BPH could be valuable as new biomarkers and
therapeutic targets. Also, differences in the pathways related to
secretome of CM-T3 or CM-T2 could be useful to determine
biomarkers or drug targets in the different stages. Pathways with
the highest number of genes identified in the three CMs were:
integrin signalling pathway, chemokine mediated inflammation,
cytokine signalling pathway and blood coagulation. On the
other hand, pathways that involved CMs-T proteins were found
in Parkinson disease, Huntington disease, B cell activation, FGF
signalling pathway, cadherin signalling pathway, EGF receptor
signalling pathway and 5-hydroxitryptamine degradation, some
of them being known tumour related-pathways. It is noteworthy
that other pathways induced by the proteins detected in CM-T3
were related to tumour signalling. Among those signalling
pathway of apoptosis, angiogenesis, interleukin, VEGF,
interferon gamma, TGF-beta, FAS, p38 MAPK, PI3 kinase,
insulin/IGF-protein kinase B cascade, insulin/IGF-MAP kinase
cascade, hypoxia response via HIF activation, vitamin D
metabolism and pathway stood out. Among the proteins of CM-
T3 secretome involved in CCKR signalling map, the growth-
regulated alpha protein (CXCL1) and C-X-C motif chemokine
2 (CXCL2), matrix metalloproteinase-9 (MMP9), isoform 2 of
plasminogen activator inhibitor 1 (SERPINE1), cAMP-
dependent protein kinase catalytic subunit beta (PRKACB), heat
shock protein beta-1 (HSPB1), ELAV-like protein 1 (ELAVL1)
and isoform 3 of tyrosine-protein phosphatase non-receptor type
11 (PTPN11), were detected. With respect to MMP-9, we have
previously reported higher activity of proMMP-9 in CMs-T
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relative to CM-BPH and that CMs-T induced a significant
increase of pro-MMP9 activity compared to CM-BPH in
LNCaP cells (10). Likewise, CXCL1 and CXCL2 are important
chemokines associated with inflammation, growth and tumour
cancer progression (64). In a murine model of lung cancer, the
secretome of cancer cells included a multitude of extracellular
proteins that increased in co-cultures with cancer-associated
fibroblasts or stromal cells; among these proteins, the
chemokine CXCL1 was abundantly produced by cancer cells
probably through paracrine signalling (65). 
To identify proteins that are overrepresented in any
functional class (referenced to human genome), the secretome
of CMs were subjected to functional enrichment analysis using
ProteiNSIDE and/or FunRich tools. The over-representation
test calculates the probability that the number of differentially
expressed genes belonging to a category is larger or smaller
than that expected based on a reference using the binomial test.
FunRich includes, exosomal and lysosomal proteins. It should
be noted that dysregulation of the function of organelles like
lysosomes, peroxisomes and endoplasmic reticulum
(components of the metabolic network) is increasingly
recognized in cancer cells. FunRich is a simple tool that allows
comparison between two selected datasets. The top ten
enriched GO annotations obtained with ProteINSIDE are listed
in Table V. The most significantly enriched GO for CM-T3,
CM-T2 and CM-BPH were extracellular exosomes (p-value:
0, <0.001 and <0.001 respectively) and extracellular region (p-
value<0.001 for all three). Also, CM-T3 secretome was
enriched in focal adhesion (p-value<0.001) and neutrophil
degranulation proteins (p-value<0.001). FunRich analysis also
showed that exosomes was the most represented cellular
component in the three CMs (CM-T3: 209 genes, 55.7%, 5.2-
fold; CM-T2: 39 genes, 32%, 62.9-fold and CM-BPH: 34
genes, 83%, 7.8-fold) following by lysosomes (CM-T3: 165
genes, 44%, 5.2-fold; CM-T2: 32 genes, 52%, 6-fold and CM-
BPH: 25 genes, 61%, 7.2-fold) (Figure 3A, B and C).
Additionally, more than 80% of CM-BPH proteins were
exosomal while, the distribution in CMs-T, was more
homogenous and other cellular compartments/organelles were
represented (Figure 3D). Many proteins, lipids, DNA and RNA
are packaged in exosomes and play an important role in cell-
to-cell communication (66). Exosomes carry a lot of
cytoplasmic and nuclear proteins out of cell to target cells.
Bioactive exosomal proteins can participate in cell
proliferation, movement, migration and adhesion which can
induce tumour metastasis. Exosomes may be capable of direct
contribution to matrix remodeling both within the tumour
microenvironment and potentially at distant sites away from
the primary tumour. Previous reports showed that exosomal are
essential to initiate a pre-metastatic niche in addition to soluble
factors and contribute in the progression of cancer (67, 68). 
We also made a selected molecular function gene
enrichment analysis of the three CMs using FunRich tool
(Figure 3E). This analysis showed that only CM-T3 was
significantly enriched in enzymes (25 genes, 6.7%, 2.4-fold, 
p-value <0.001), structural molecules (13 genes, 3.5%, 2.5-
fold, p-value=0.04), calcium ion binding proteins (12 genes,
3.2%, 3.3-fold, p-value <0.001), chaperons (9 genes, 2.4%, 3.7-
fold, p-value=0.02) and complement proteins (7 genes, 1.9%,
12.9-fold, p-value=0.02). Defense/immunity proteins were
enriched in CM-T2 (4 genes, 6.4%, 20.4-fold, p-value=0.005).
Analysis of biological processes indicated that cell growth and/or
maintenance proteins were the most significantly enriched in the
three CMs (CM-T3: 84 genes, 22.4%, 3.8-fold, p-value<0.001;
CM-T2: 20 genes, 32.3%, 5.5-fold, p-value<0.001; CM-BPH:
14 genes, 34.1%, 5.8-fold, p-value<0.001). The biological
process proteins that were significantly represented in CM-T3
secretome included protein metabolism (60 genes, 16%, 2.3-fold,
p-value <0.001), general metabolism (63 genes, 16.8%, 1.9-fold,
p-value <0.001 and energy pathways (62 genes, 16.5%, 1.9-fold,
p-value <0.001). Immune response proteins were represented in
CM-T3 (24 genes, 6.4%, 2.1-fold, p-value=0.015) and CM-T2
(5 genes, 8%, 2.7-fold, p-value=0.04), while transport proteins
were enriched (p-value=0.04) in CM-T2 (8 genes, 13%, 20-fold)
and CM-BPH (6 genes, 14.6%, 2.3-fold) secretomes (Figure 3F). 
A complementary analysis was performed to determine
enrichment or depletion at the GO molecular function level
during PCa progression. Dataset of CM-T3 or CM-T2 were
compared to CM-BPH (Figure 4A and B, respectively) and
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Table IV. Biological pathways associated with proteins of conditioned
media from periprostatic adipose tissue involving at least 4 genes.
CM       Pathway                                                                          # Genes
T3        Integrin signalling pathway (P00034)                                25
             Inflammation mediated by chemokine and 
             cytokine signaling pathway (P00031)                               15
             Parkinson disease (P00049)                                                13
             Blood coagulation (P00011)                                               12
             Cytoskeletal regulation by Rho GTPase (P00016)             9
             Nicotinic acetylcholine receptor signaling 
             pathway (P00044)                                                                 9
             Plasminogen activating cascade (P00050)                           8
             CCKR signaling map (P06959)                                            8
             Glycolysis (P00024)                                                              7
             Alzheimer disease-presenilin pathway (P00004)                5
             Gonadotropin-releasing hormone receptor 
             pathway (P06664)                                                                 5
             Huntington disease (P00029)                                               4
             Wnt signaling pathway (P00057)                                         4
             FGF signaling pathway (P00021)                                        4
T2         Integrin signalling pathway (P00034)                                  7
             Blood coagulation (P00011)                                                 5
             Inflammation mediated by chemokine and 
             cytokine signaling pathway (P00031)                                 4
BPH     Integrin signalling pathway (P00034)                                  7
           Blood coagulation (P00011)                                                 5
also between the two stages (T3 and T2) of PCa (Figure 4C).
According to the molecular functions, CM-T3 secretome was
enriched (compared to CM-BPH) in ubiquitin specific proteins
(87.6-fold), complement proteins (76.7-fold), transcription
regulators and oxidoreductase (65.7-fold), RNA and DNA
binding proteins (54.8-fold and 43.9, respectively), serine-type
peptidases, defense/immunity proteins (43.9-fold), chemokines
(32.9-fold), metallopeptidases (22-fold) and cell adhesion
molecules (1.3-fold). Contrarily, the CM-T3 secretome was
depleted from heat shock proteins (4.6-fold), binding proteins
(3.4-fold), translation regulators, receptors and transporters
(3.1-fold), and structural constituents of cytoskeleton (2.3-
fold) (Figure 4A). The CM-T2 secretome was enriched
(compared to CM-BPH) in defense/immunity proteins (265.2-
fold), peptidases and receptor signalling complexes and
scaffold activity (132.9-fold); transcription factors complement
proteins, RNA binding proteins, ubiquitin specific proteases,
aldehyde dehydrogenases and superoxide dismutase (all 66.5-
fold) (Figure 5B). By contrast, the CM-T2 secretome was
depleted from heat shock proteins, translation regulators and
peroxidases (152.7-fold) and protein binding (4.5 fold) (Figure
4B). Comparison between the two stages of PCa showed that
CM-T3 secretome was enriched (compared to CM-T2) in
transcription regulators and oxidoreductases (99.4-fold),
peroxidases (82.8-fold), serine-type peptidases, DNA binding
(66.3-fold), chemokines and ATPases (49.8-fold),
metallopeptidases, complement proteins and heat shock
proteins (33.3-fold change), glutathione transferases and
growth factors (16.7-fold) (Figure 4C). By contrast, the CM-
T3 secretome was depleted from transcription factors (300-
fold), peptidases and defense/immunity proteins (6.0-fold),
superoxide dismutases, structural constituents of cytoskeleton
and aldehyde dehydrogenases (3.0-fold), transporter (2.7-fold),
receptor signalling complexes and scaffold proteins (2.4-fold),
receptor binding and activity (2.0-fold) (Figure 4C). With
respect to biological processes GO, CM-T3 secretome was
enriched (compared to CM-BPH) in cytoskeleton organization
and biogenesis proteins (32.9-fold), apoptosis and regulation
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Table V. ProteINSIDE gene enrichment analysis. List of top ten multiple annotations GOs for each conditioned media from periprostatic adipose
tissue.
CM              GO number                                      Function                                     GO                Count                  GO frequency                     p-Value
                                                                                                                                              of protein         within the dataset (%)                   BH
T3               GO:0070062                          Extracellular exosome                          CC                  272                           66.5                                     0
                   GO:0005576                            Extracellular region                            CC                  174                           42.5                             7.62E-183
                   GO:0005515                               Protein binding                                MF                  256                           62.6                             2.79E-174
                   GO:0005615                            Extracellular space                             CC                  136                           33.3                             1.28E-144
                   GO:0005829                                      Cytosol                                       CC                  176                               43                             4.63E-119
                   GO:0072562                           Blood microparticle                            CC                    64                           15.7                             4.67E-103
                   GO:0031012                           Extracellular matrix                            CC                    75                           18.3                             4.13E-100
                   GO:0005925                                Focal adhesion                                CC                    56                           13.7                              7.83E-71
                   GO:0043312                       Neutrophil degranulation                        BP                    59                           14.4                              1.73E-70
                   GO:0002576                          Platelet degranulation                           BP                    41                               10                              3.90E-65
T2               GO:0070062                          Extracellular exosome                          CC                    57                           81.4                              2.61E-62
                   GO:0005576                            Extracellular region                            CC                    39                           55.7                              1.39E-44
                   GO:0072562                           Blood microparticle                            CC                    21                               30                              1.35E-39
                   GO:0005615                            Extracellular space                             CC                    30                           42.9                              1.10E-34
                   GO:0005515                               Protein binding                                MF                    47                           67.1                              4.84E-33
                   GO:0002576                          Platelet degranulation                           BP                    14                               20                              2.07E-26
                   GO:0005829                                      Cytosol                                       CC                    35                               50                              1.99E-25
                   GO:0031012                           Extracellular matrix                            CC                    17                           24.3                              8.22E-25
                   GO:0005788                   Endoplasmic reticulum lumen                    CC                    14                               20                              1.81E-21
                   GO:0005200             Structural constituent of cytoskeleton              MF                    10                               45                              3.45E-18
BPH            GO:0070062                          Extracellular exosome                          CC                    41                           89.1                              9.52E-46
                   GO:0005576                            Extracellular region                            CC                    30                           65.2                              9.21E-36
                   GO:0072562                           Blood microparticle                            CC                    15                           32.6                              1.06E-28
                   GO:0002576                          Platelet degranulation                           BP                    14                           30.4                              1.31E-28
                   GO:0005615                            Extracellular space                             CC                    23                               50                              7.04E-28
                   GO:0031012                           Extracellular matrix                            CC                    16                           34.8                              1.79E-25
                   GO:0005515                               Protein binding                                MF                    32                           69.6                              6.45E-23
                   GO:0031093                    Platelet alpha granule lumen                     CC                    10                           21.7                              8.96E-22
                   GO:0005829                                      Cytosol                                       CC                    26                           56.5                              5.08E-20
                   GO:0005788                   Endoplasmic reticulum lumen                    CC                    12                         17.39                              5.98E-11
CANCER GENOMICS & PROTEOMICS 16: 29-58 (2019)
40
Figure 3. Column charts of the subcellular localization of proteins. A) CM-T3. B) CM-T2. C) CM-BPH. Bar chart of represented cellular
compartments (D); molecular functions (E) and biological processes (F), according to FunRich analysis.
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Figure 4. Bar charts of enrichment and depletion of molecular
functions in the secretome of CM-T3 compared to CM-BPH (A);
CM-T2 compared to CM-BPH (B) and CM-T3 compared to CM-
T2 (C). Enrichment and depletion of biological processes in the
secretome of CM-T3 compared to CM-BPH (D), CM-T2
compared to CM-BPH (E) and CM-T3 compared to CM-T2 (F),
according to FunRich analysis.
of cell cycle proteins (22-fold), aldehyde metabolism and cell
differentiation proteins (11-fold), immune response proteins
(2.6-fold), signal transduction and energy pathway proteins
(1.4-fold) (Figure 4D). By contrast, the CM-T3 secretome was
depleted in cell communication proteins (1.7-fold), cell
adhesion molecules (9.1-fold), transport (2-fold) and cell
growth and/or maintenance (1.5-fold) (Figure 4D). CM-T2
secretome was enriched (compared to CM-BPH) in aldehyde
metabolism (66.8-fold), cytoskeleton organization and
biogenesis (66.8-fold), immune response (3.3-fold), cell
communication (1.3-fold), signal transduction (1.2-fold)
proteins (Figure 4E). By contrast, it was depleted in cell
adhesion (152.7-fold), protein metabolism, energy pathways
and metabolism (1.3-fold), transport and cell growth and/or
maintenance (1.1-fold) proteins (Figure 4Ε). Furthermore,
CM-T3 secretome was enriched (compared to CM-T2) in
apoptosis and regulation of the cell cycle (33.2-fold), cell
differentiation, lipid metabolism and cell adhesion (16.7-fold),
metabolism and energy pathways (1.7-fold), protein
metabolism (1.4-fold), cell communication (1.3-fold) and
signal transduction (1.2-fold) proteins (Figure 4F). By
contrast, CM-T3 secretome was depleted (compared to CM-
T2) in aldehyde metabolism and cytoskeletal anchoring (6.0-
fold), cytoskeleton organization and biogenesis (2.0-fold),
transport (1.7-fold), cell growth and/or maintenance (1.4-fold)
and immune response (1.4-fold) proteins (Figure 4F).
The top ten enriched biological pathways for each CMs are
shown in Table VI. The integrin family cell surface interaction
was the more enriched pathway for CM-T3 (80 genes, 
p-value <0.001), homeostasis pathway was for CM-T2 (11
genes, p-value <0.001) and TRAIL signalling pathway was for
CM-BPH (15 genes, p-value<0.001) (Table VI). Some
significantly enriched pathways exclusive for the CMs-T are
shown in Figure 5A and B. These include: Immune system,
adaptive immune system, L1CAM interactions, NCAM
signalling for neurite out-growth, complement cascade, co-
stimulation by the CD28 family, CD28 co-stimulation, initial
triggering of complement, CD28 dependent Vav1 pathway and
interaction between L1 and Ankyrins (Figure 5A). Proteins of
the spectrin family (SPTA1, SPTAN1 and SPTBN1), talin1
(TLN1) and complement 4 (C4) were common proteins to this
set of biological pathways. TLN1 is a focal adhesion complex
protein that regulates integrin interactions with the ECM and is
up-regulated during adipogenesis (69). Their overexpression
enhanced PCa cell adhesion, migration and invasion by
activating survival signals and conferring resistance to anoikis
(70). Other proteins involved in these pathways were laminins
(LAMB1, LAMC1), proteins of complement family (C1QB,
C1QC, C3, C5, C9), proteasome subunits (PSMA1, PSMA5,
PSMA6, PSMA7, PSMB1, PSMB4, PSMB5), 14-3-3 protein
gamma (YWHAG and YWHAZ) and several cell adhesion
molecules. NCAM pathway is induced by cell adhesion
molecules like neural cell adhesion molecule 1 (NCAM1) and
cadherins. Loss of NCAM function during tumour progression
affects cell–matrix adhesion and integrin-mediated cell-matrix
adhesion (71). Some other detected cell adhesion molecules of
this pathways were tyrosine-protein phosphatase non-receptor
type 11 (PTPN11) that mediate signal transduction and promote
adipogenesis (72); isoform Delta14-15 of platelet endothelial
cell adhesion molecule (PECAM1/CD31) involved in
angiogenesis (73). On the other hand, regulation of cytoskeletal
remodeling and cell spreading by IPP complex components was
the most enriched pathway in CM-T3 and CM-BPH. Pathways
exclusively enriched in CM-T3 secretome are shown in Figure
5B. Pathways related to metabolism were aspartate degradation
II and TCA cycle variation III (eukaryotic) through malate
dehydrogenase cytoplasmic (MDH1), malate dehydrogenase
(MDH2), aspartate aminotransferase (GOT1) and cytoplasmic
aconitate hydratase (ACO1) proteins. MDH2 expression was
reported to be elevated in PCa cell lines compared to BPH
epithelial cells and that it regulates chemotherapy-induced
signal transduction and oxidative metabolism (74). The
metabolic pathway of particular interest was that related with
Warburg effect and through pyruvate fermentation to lactate (p-
value 0.03) allows rapid biosynthesis to support growth and
proliferation of cancer cells. This pathway represented by L-
lactate dehydrogenase B chain (LDHB) and isoform 4 of L-
lactate dehydrogenase A chain (LDHA). Pathways associated to
immune system were also enriched, C3 and C5 proteins,
alternative complement activation, classical antibody-mediated
complement activation and Interleukin-3, 5 and GM-CSF
signalling. Regarding advanced glycosylation endproduct
receptor (RAGE) signalling three proteins were detected in CM-
T3: f-actin-capping protein subunit alpha-2 (CAPZA2), isoform
2 of glucosidase 2 subunit beta (PRKCSH, substrate for protein
kinase C) and protein S100-B (S100B). Advanced glycation end
products (AGE) derived from endogenous nonenzymatic
glycation and AGE-associated signalling pathways play a key
role in aging-dependent adiposity through the pro-adipogenic
function of senescent preadipocytes (75). Interestingly, it has
recently been shown that RAGE pathway may play a role in
malignant transformation of MSCs, and that this process may
be mediated through S100B. Glioma-conditioned medium and
recombinant S100B increased RAGE and its downstream Akt1,
STAT3 genes expression as well as phosphorylation and
transcriptional activation (76). 
Additional FunRich analysis was carried out to get
information about sites of protein expression (Figure 5C and
D). The analysis showed that most of proteins in CMs are
plasma proteins (CM-BPH and CM-T2 100%, CM-T3 94%);
the percentage of serum proteins decreased as disease
becomes more malignant (CM-BPH 95%, CM-T2 90% and
CM-T3 80%) (Figure 5C). Thus, CMs-T would have higher
percentage of coagulation factors genes (CM-T3 14%, CM-
T2 10%) relative to benign disease (CM-BPH 5%).
Accumulating evidence indicates the potential interaction of
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Figure 5. Bar charts of exclusive enriched biological pathways for
CMs-T (A) and for CM-T3 (B). Bar charts of sites of protein
expression (C and D). Bar charts of relative exponentially
modified protein abundance index (emPAI) with at least two-fold
change. (E) Between CM-T3, CM-T2 and CM-BPH; (F) between
CM-T2 and CM-T3; (G) between CM-T3 and CM-BPH, according
FunRich analysis.
the coagulation system and malignant processes, suggesting
a state of hypercoagulability when cancer is present (77).
However, the exact mechanisms by which coagulation
proteins promote tumourigenesis are not fully understood,
and are likely related to peritumoural deposition of fibrin and
to alteration of homeostatic factors, hence favoring
proliferation, angiogenesis and metastasis (78). Also, it has
been reported that the thrombin–antithrombin complex was
associated with Gleason score and fibrinogen with higher
tumour stages (II-IV) (79). 
On the other hand, urine represents a non-invasive and
important source of biomarkers for the early detection of
PCa since it contains secreted prostatic products and
exfoliated tumour cells. A significant percentage of CM-BPH
and CM-T2 proteins were found in urine (86 and 88 %
respectively) relative to CM-T3 (70%) (Figure 5C). 
During their interaction with cancer cells, adipocytes can
dedifferentiate into pre-adipocytes or being reprogrammed
into cancer-associated adipocytes (CAA). There was a
significant percentage of genes expressed in preadipocytes
(CM-T3 32%, CM-T2 42% and CM-BPH 56%) and their
percentage diminished as disease advanced, but no statistical
difference was found in the percentage of adipocyte proteins
expressed in CM-T2 and CM-BPH while it was significant
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Table VI. Top ten enriched biological pathways for conditioned media from periprostatic adipose tissue according to FunRich analysis.
Top ten enriched biological pathways                                         # Genes                  % Genes                Fold enrichment                 p-Value BH method
CM-T3                                                                                                                                                                                                                    
Integrin family cell surface interactions                                           80                           21.3                              3.0                                     6.7E-16 
Hemostasis                                                                                         40                           10.7                              5.5                                     1.1E-15
Beta1 integrin cell surface interactions                                            78                           20.8                              3.0                                     1.1E-15
Integrin cell surface interactions                                                       18                             4.8                            12.8                                     7.3E-13
Beta3 integrin cell surface interactions                                            14                             3.7                            16.7                                     1.4E-11
TRAIL signaling pathway                                                                 68                           18.1                              2.6                                     4.0E-11
Epithelial-to-mesenchymal transition                                               24                             6.4                              6.7                                     5.3E-11
Proteoglycan syndecan-mediated signaling events                          68                           18.1                              2.6                                     5.2E-11
Cell-Cell communication                                                                  19                             5.1                              8.3                                     2.3E-10
Syndecan-1-mediated signaling events                                             65                           17.3                              2.6                                     2.5E-10
CM-T2                                                                                                                                                                                                                    
Hemostasis                                                                                         11                           17.7                              9.1                                     1.6E-05
Platelet degranulation                                                                          5                             8.1                            55.5                                     1.6E-05
Muscle contraction                                                                              6                             9.7                            31.3                                     1.6E-05
Response to elevated platelet cytosolic Ca2+                                     5                             8.1                            39.8                                     5.2E-05
Apoptotic cleavage of cellular proteins                                              5                             8.1                            39.8                                     5.2E-05
Apoptotic execution phase                                                                  5                             8.1                            32.4                                      0.0001
Apoptosis                                                                                              7                           11.3                            13.8                                      0.0002
Smooth Muscle Contraction                                                                4                             6.5                            51.8                                      0.0002
Formation of Fibrin Clot (Clotting Cascade)                                     4                             6.5                            37.7                                      0.0007
Caspase-mediated cleavage of cytoskeletal proteins                         3                             4.8                            84.8                                      0.0009
CM-BPH                                                                                                                                                                                                                
TRAIL signaling pathway                                                                 15                           36.6                              5.3                                     2.7E-05
Integrin family cell surface interactions                                           15                           36.6                              5.1                                     2.7E-05
Beta1 integrin cell surface interactions                                            15                           36.6                              5.2                                     2.7E-05
Proteoglycan syndecan-mediated signaling events                          15                           36.6                              5.2                                     2.7E-05
Epithelial-to-mesenchymal transition                                                 7                           17.1                            17.8                                     3.9E-05
Hemostasis                                                                                           8                           19.5                            10.0                                     7.3E-05
Syndecan-1-mediated signaling events                                             13                           31.7                              4.7                                     7.3E-05
Glypican pathway                                                                              14                           34.1                              4.9                                     7.3E-05
GMCSF-mediated signaling events                                                  13                           31.7                              4.7                                     7.3E-05
Insulin Pathway                                                                                 13                           31.7                              4.7                                     7.3E-05
BH: Benjamini-Hochberg.
Table VII. Number of potentially secreted proteins from conditioned
media as predicted for classical and non-classical pathways according
to ProteinINSIDE tool.
CM             # Proteins        Classical pathway       Non-classical pathway
                                                  # Proteins                        # Proteins
T3                   563                   150 (27%)                      169 (30%)
T2                     78                     29 (37%)                        33 (42%)
BPH                  52                     17 (33%)                        21 (42%)
Sacca et al: Secretome of Human Periprostatic Adipose Tissue
45
Table VIII. List of proteins secreted by classical pathways according to ProteINSIDE tool.
                    
CM                         Biological process                                                                                GN                                   Molecular function
T3                           Cell growth and/or maintenance
                               Isoform 2 of Laminin subunit alpha-4                                           LAMA4                     Cell adhesion molecule activity
                               Laminin subunit alpha-5                                                                 LAMA5                                              "
                               Cadherin-5 (Fragment)                                                                     CDH5                                               "
                               Isoform 3 of Cadherin-13                                                               CDH13                                              "
                               Prolargin                                                                                           PRELP                      Cytoskeletal anchoring activity
                               Basement membrane-specific                                                                                                                      
                               heparan sulfate proteoglycan core protein                                      HSPG2                          ECM structural constituent
                               Laminin subunit gamma-1                                                              LAMC1                                              "
                               Laminin subunit beta-1                                                                    LAMB1                                               "
                               Lumican                                                                                             LUM                                                 "
                               Isoform 4 of Collagen alpha-1(XII) chain                                   COL12A1                                             "
                               Isoform 2 of Nidogen-1                                                                    NID1                                                "
                               Collagen alpha-2(VI) chain                                                           COL6A2                                             "
                               EMILIN-1                                                                                       EMILIN1                                             "
                               Laminin subunit alpha-2                                                                 LAMA2                                              "
                               Extracellular matrix protein 1                                                          ECM1                                               "
                               Collagen alpha-2(I) chain                                                              COL1A2                                              "
                               Vitronectin                                                                                          VTN                                                 "
                               Spondin-1                                                                                         SPON1                                               "
                               Fibrillin-1                                                                                          FBN1                                                "
                               Procollagen C-endopeptidase enhancer 1                                     PCOLCE                                              "
                               Latent-transforming growth                                                                                                                         
                               factor beta-binding protein 2                                                           LTBP2                                                "
                               Collagen alpha-1(VI) chain                                                           COL6A1                                              "
                               Decorin (Fragment)                                                                           DCN                                                 "
                               Chitinase-3-like protein 1                                                               CHI3L1                                               "
                               Microfibril-associated glycoprotein 4                                            MFAP4                                               "
                               Cartilage intermediate layer protein 1                                              CILP                                                 "
                               Collagen alpha-1(I) chain                                                              COL1A1                                              "
                               Myocilin                                                                                           MYOC                                    Motor activity
                               Isoform 2 of Gelsolin                                                                        GSN                   Structural constituent of cytoskeleton
                               Afamin                                                                                               AFM                          Structural molecule activity
                               Protein metabolism                                                                                                                                       
                               Serum amyloid P-component                                                           APCS                                           Binding
                               Carboxypeptidase M                                                                          CPM                            Carboxypeptidase activity
                               Mast cell carboxypeptidase A                                                           CPA3                                                 "
                               78 kDa glucose-regulated protein                                                   HSPA5                                 Chaperone activity
                               Calreticulin (Fragment)                                                                    CALR                                                "
                               Protein disulfide-isomerase A6                                                       PDIA6                                 Isomerase activity
                               Matrix metalloproteinase-9                                                              MMP9                            Metallopeptidase activity
                               Neutrophil collagenase                                                                     MMP8                                                "
                               Plasminogen                                                                                       PLG                                   Peptidase activity
                               Thrombin light chain                                                                           F2                                     Peptidase activity
                               Isoform 2 of Inter-alpha-trypsin inhibitor heavy chain H5            ITIH5                            Protease inhibitor activity
                               Isoform 4 of Inter-alpha-trypsin inhibitor heavy chain H4            ITIH4                                                "
                               Inter-alpha-trypsin inhibitor heavy chain H2                                  ITIH2                                                "
                               Plasma protease C1 inhibitor                                                       SERPING1                                            "
                               Isoform 2 of Alpha-2-antiplasmin                                               SERPINF2                                            "
                               Heparin cofactor 2                                                                        SERPIND1                                            "
                               Kallistatin                                                                                      SERPINA4                                            "
                               von Willebrand factor                                                                        VWF                                     Protein binding
                               Isoform 2 of Tryptase alpha/beta-1                                               TPSAB1                      Serine-type peptidase activity
                               CMA1 protein                                                                                   CMA1                                                "
                               Neutrophil elastase                                                                          ELANE                                               "
                               Immune response                                                                                                                                          
                               Zinc-alpha-2-glycoprotein                                                               AZGP1                     Cell adhesion molecule activity
                               Platelet factor 4                                                                                   PF4                                   Chemokine activity
Table VIII. Continued
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Table VIII. Continued
CM                         Biological process                                                                                GN                                   Molecular function
                               Growth-regulated alpha protein                                                      CXCL1                                              "
                               C-X-C motif chemokine 2                                                              CXCL2                                              "
                               Complement C3                                                                                   C3                                  Complement activity
                               Complement factor H-related protein 1                                         CFHR1                                               "
                               Complement component C9                                                                C9                                                   "
                               Complement factor D                                                                         CFD                                                 "
                               Complement C1q subcomponent subunit C                                    C1QC                                                "
                               Complement C1s subcomponent (Fragment)                                    C1S                                                  "
                               Complement C5                                                                                   C5                                                   "
                               Clusterin beta chain (Fragment)                                                       CLU                                                 "
                               Complement decay-accelerating factor                                            CD55                                                "
                               Complement factor H                                                                        CFH                                Complement binding
                               Azurocidin                                                                                         AZU1                     Defense/immunity protein activity
                               Galectin-3-binding protein                                                           LGALS3BP                      ECM structural constituent
                               Serglycin                                                                                           SRGN                                                "
                               Beta-2-microglobulin                                                                         B2M                         MHC class I receptor activity
                               Isoform 3 of CD109 antigen                                                           CD109                        Molecular function unknown
                               Cell communication; Signal transduction                                                                                                    
                               Cell surface glycoprotein MUC18                                                  MCAM                      Cell adhesion molecule activity
                               Periostin                                                                                           POSTN                                              "
                               Isoform Delta14-15 of Platelet                                                      PECAM1                                             "
                               endothelial cell adhesion molecule                                                                                                              
                               Dystroglycan                                                                                     DAG1                                                "
                               Isoform 6 of Tenascin                                                                         TNC                                                 "
                               G-protein coupled receptor 124                                                     GPR124                  G-protein coupled receptor activity
                               Peptidyl-prolyl cis-trans isomerase FKBP2                                   FKBP2                                Isomerase activity
                               ADM2                                                                                               ADM2                                  Peptide hormone
                               Chondroitin sulfate proteoglycan 4                                                CSPG4                                   Protein binding
                               Scavenger receptor cysteine-rich type 1 protein M130                 CD163                                  Receptor activity
                               Prolow-density lipoprotein receptor-related protein 1                    LRP1                                                 "
                               Signal-regulatory protein beta-1 isoform 3                                    SIRPB1                                               "
                               Bone morphogenetic protein 3                                                         BMP3                                                "
                               Isoform 3 of Receptor-type tyrosine-protein phosphatase S         PTPRS        Receptor signaling protein tyr phosphatase activity
                               Receptor-type tyrosine-protein phosphatase T                               PTPRT                                               "
                               Transport
                               Isoform 4 of Chloride channel CLIC-like protein 1                      CLCC1                                Ion channel activity
                               Isoform DeltaLf of Lactotransferrin                                                  LTF                                  Transporter activity
                               Transthyretin                                                                                       TTR                                                  "
                               Vitamin D-binding protein                                                                  GC                                                   "
                               Neutrophil gelatinase-associated lipocalin                                      LCN2                                                "
                               Apolipoprotein E (Fragment)                                                           APOE                                               "
                               Apolipoprotein C-III                                                                       APOC3                                               "
                               Apolipoprotein D (Fragment)                                                          APOD                                               "
                               Apolipoprotein B-100                                                                       APOB                                                "
                               Adaptive immunity, Immunity                                                                                                                     
                               Ig lambda chain V-IV region Hil                                                  IGLV3-25                       Antigen binding/serine-type 
                                                                                                                                                                                    endopeptidase activity
                               Ig kappa chain V-I region Wes                                                   IGKV1D-12                                           "
                               Ig heavy chain V-III region VH26                                               IGHV3-23                                             "
                               Ig heavy chain V-III region BUT                                                 IGHV3-53                                             "
                               Ig kappa chain V-I region HK102 (Fragment)                             IGKV1-5                                             "
                               Ig heavy chain V-I region V35                                                      IGHV1-2                                              "
                               Ig heavy chain V-III region JON                                                   IGHV3-7                                              "
                               Metabolism; Energy pathways                                                                                                                     
                               Liver carboxylesterase 1                                                                   CES1                                  Hydrolase activity
                               Isoform 2 of Arylsulfatase A                                                            ARSA                                   Catalytic activity
                               Epoxide hydrolase 1                                                                        EPHX1                                Hydrolase activity
                               Lysozyme C                                                                                        LYZ                                                  "
Table VIII. Continued
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Table VIII. Continued
CM                         Biological process                                                                                GN                                   Molecular function
                               Ceruloplasmin                                                                                      CP                                Oxidoreductase activity
                               Isoform H14 of Myeloperoxidase                                                     MPO                                                 "
                               Glutathione peroxidase 3                                                                  GPX3                                 Peroxidase activity
                               Isoform 2 of Glucosidase 2 subunit beta                                      PRKCSH                              Glucosidase activity
                               Apoptosis
                               Histidine-rich glycoprotein                                                               HRG                                           Binding
                               Peroxidasin homolog (Fragment)                                                    PXDN                                 Peroxidase activity
                               Organogenesis; Cell communication; Signal transduction                                                                         
                               Mimecan                                                                                             OGN                                Growth factor activity
                               Regulation of nucleobase, nucleoside, 
                               nucleotide and nucleic acid metabolism                                                                                                      
                               Non-secretory ribonuclease                                                           RNASE2                            Ribonuclease activity
                               Signal transduction; Cell migration; Morphogenesis; 
                               Immune response                                                                                                                                          
                               Neuropilin-1                                                                                      NRP1                                   Receptor activity
                               L-arabinose metabolic process                                                                                                                     
                               Otogelin-like protein                                                                       OTOGL                 Alpha-L-arabinofuranosidase activity
                               Biological_process unknown
                               Isoform 2 of Target of Nesh-SH3                                                  ABI3BP                       Molecular function unknown
                               Isoform 2 of NAD(P)H-hydrate epimerase                                 APOA1BP                                            "
                               LOC644656 protein (Fragment)                                                  LOC644656                                           
T2                           Adaptive immunity, Immunity                                                                                                                     
                               Ig heavy chain V-III region KOL                                                 IGHV3-33                      Antigen binding/serine-type 
                                                                                                                                                                                    endopeptidase activity
                               Ig heavy chain V-II region ARH-77                                             IGHV4-34                                             "
                               Protein metabolism
                               Coagulation factor XII                                                                       F12                                     Peptidase activity
                               Cell communication; Signal transduction                                                                                                    
                               Alpha-2-HS-glycoprotein                                                                 AHSG                    Defense/immunity protein activity
T3 and T2              Immune response
                               Isoform 2 of Complement C4-A                                                       C4A                                 Complement activity
                               Alpha-1-acid glycoprotein 1                                                             ORM1                    Defense/immunity protein activity
                               Alpha-1-acid glycoprotein 2                                                            ORM2                                               "
                               Pentraxin-related protein PTX3                                                       PTX3                                                "
                               Biological_process unknown
                               Olfactomedin-like protein 1                                                          OLFML1                      Molecular function unknown
                               Leucine-rich alpha-2-glycoprotein                                                    LRG1                                                "
                               Endosialin                                                                                          CD248                                  Receptor activity
                               Protein metabolism
                               Antithrombin-III                                                                           SERPINC1                        Protease inhibitor activity
                               Lysyl-bradykinin                                                                                KNG1                                                "
                               Isoform Gamma-A of Fibrinogen gamma chain                               FGG                                     Protein binding
                               Cell communication; Signal transduction                                                                                                    
                               Basal cell adhesion molecule (Fragment)                                      BCAM                      Cell adhesion molecule activity
                               Cell growth and/or maintenance
                               Tenascin-X OS=Homo sapiens                                                        TNXB                          ECM structural constituent
                               Laminin subunit beta-2                                                                    LAMB2                                              "
                               Adaptive immunity, Immunity                                                                                                                     
                               Ig lambda chain V-III region LOI                                                IGLV3-21                       Antigen binding/serine-type 
                                                                                                                                                                                    endopeptidase activity
                               Metabolism; Energy pathways                                                                                                                     
                               Extracellular superoxide dismutase [Cu-Zn]                                   SOD3                        Superoxide dismutase activity
                               Transport
                               Beta-2-glycoprotein 1                                                                       APOH                                 Transporter activity
T3 and BPH           Protein metabolism
                               Isoform 2 of Plasminogen activator inhibitor 1                          SERPINE1                       Protease inhibitor activity
                               Fibrinogen beta chain                                                                         FGB                                      Protein binding
                               Isoform 2 of Fibrinogen alpha chain                                                FGA                                                 "
Table VIII. Continued
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Table VIII. Continued
CM                         Biological process                                                                                GN                                   Molecular function
                               Cell growth and/or maintenance
                               Isoform 10 of Fibronectin                                                                  FN1                            ECM structural constituent
                               Collagen alpha-1(XV)                                                                    COL15A1                                             "
                               Transport
                               Hemopexin                                                                                         HPX                                 Transporter activity
                               Apolipoprotein A-IV                                                                       APOA4                               Transporter activity
                               Biological_process unknown
                               Isoform 2 of Alpha-1B-glycoprotein                                               A1BG                        Molecular function unknown
T2 and BPH           Transport
                               Apolipoprotein A-II                                                                         APOA2                               Transporter activity
T3, T2 and BPH    Protein metabolism and/or Immune response
                               Alpha-2-macroglobulin                                                                     A2M                             Protease inhibitor activity
                               Isoform 2 of Alpha-1-antitrypsin                                                 SERPINA1                                            "
                               Haptoglobin (Fragment)                                                                      HP                                   Transporter activity
                               Cell growth and/or maintenance
                               Isoform 2 of Collagen alpha-3(VI) chain                                     COL6A3                        ECM structural constituent
                               Thrombospondin-1                                                                           THBS1                                               "
                               Transport
                               Serotransferrin                                                                                     TF                                    Transporter activity
                               Apolipoprotein A-I                                                                          APOA1                                               "
                               Adaptive immunity, Immunity                                                                                                                     
                              Ig kappa chain V-I region AG                                                     IGKV1D-33                     Antigen binding/serine-type 
                                                                                                                                                                                    endopeptidase activity
in CM-T3 (3.2%) (Figure 5D). Allot et al. (80) showed that
the highest degree of differential genetic regulation of a
poorly differentiated esophageal adenocarcinoma, appeared
when the cell line was co-cultured with whole visceral
adipose tissue, speculating that the cells of the stromal
vascular fraction (source rich in preadipocytes) are the main
effectors of these genetic alterations, since under coculture
with adipocytes the effect decreased. This could relate to the
results of this study because a higher percentage of
preadipocyte relative to adipocyte genes were detected in
more advanced disease. It can be hypothesized that 1) the
lower percentage of preadipocyte proteins in CMs-T could
be due to a diminished number of these cells since they
could have migrated towards the tumour; 2) adipocytes from
fat of tumour samples could have dedifferentiated into
preadipocytes and reprogrammed into CAA. However, a
minor percentage of adipocyte proteins could suggest some
accidental adipose tissue damage both during isolation and
over time under culture conditions; 3) this comparison
should consider which molecules are expressed by
adipocytes and preadipocytes from healthy individuals, when
it is already known that tumour cells can induce different
cells within adipose tissue to secrete a particular pattern of
molecules (6, 16, 17, 81). On the other hand, a comparison
of the proteins from our CMs showed that more than 50%
were expressed in both prostate gland and PCa (Figure 5D). 
Classification of secreted proteins. CMs proteins were analyzed
for the possibility of secretion using ProteINSIDE database and
further subjected to bioinformatics analysis. This omic tool
identifies proteins secreted through the classical pathway
(endoplasmic reticulum/Golgi apparatus dependent pathway) by
the SignalP tool as well as proteins secreted by non-classical
pathway or ER/Golgi-independent pathways. ProteINSIDE
checks the subcellular location of proteins and compares their
annotation relatively to the list of GO terms related to secretion.
Lastly, to support these predictions (classical and non-classical
pathways) ProteINSIDE runs the TargetP software that predicts
the subcellular location of the proteins using the amino acid
sequence. The double query of protein secretion, both by the
signal peptide prediction and the GO annotation, is unique to
ProteINSIDE. The number of predicted CMs proteins secreted
by classical and non-classical pathways is shown in Table VII.
CM-T2 and CM-BPH had the higher percentage of secreted
proteins (74 and 79%, respectively) relative to CM-T3 (58%)
by both classical and non-classical pathways. This could be
related to the fact that CM-T3 proteins showed a more uniform
distribution in different cellular compartments (Figure 3D)
unlike CM-BPH where more than 80% of their proteins were
exosomal. Table VIII shows the list of proteins secreted by
classical pathways for the three CMs and Table IX lists proteins
potentially secreted by pathways that do not involve signal
peptide (non-classical pathways). 
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Table IX. List of proteins secreted by non-classical pathways according to ProteINSIDE tool.
CM                         Biological process                                                                         Gene name                             Molecular function
T3                           ATP biosynthetic process; Cannonical glycolysis                                                                                       
                               Pyruvate kinase isozymes M1/M2                                                    PKM                               ADP and ATP binding 
                               Biosynthetic process                                                                                                                                     
                               Isoform 2 of Adipocyte plasma membrane-associated protein         APMAP                             Arylestearasa activity
                               Cell communication; Signal transduction                                                                                                    
                               Isoform 4 of A-kinase anchor protein 9                                          AKAP9           Receptor signaling complex scaffold activity
                               EH domain-containing protein 1                                                      EHD1                                Calcium ion binding
                               Extended synaptotagmin-1                                                              ESYT1                                               "
                               Hippocalcin-like protein 1                                                             HPCAL1                                              "
                               Plastin-2                                                                                             LCP1                                                 "
                               Myosin regulatory light chain 12A                                               MYL12A                                             "
                               Phosphatidylethanolamine-binding protein 1                                 PEBP1                          Protease inhibitor activity
                               cAMP-dependent protein kinase catalytic                                    PRKACB              Protein serine/threonine kinase activity
                               subunit beta (Fragment) 
                               Isoform 2 of Receptor-type tyrosine-protein                                 PTPRG                          Receptor signaling protein 
                               phosphatase gamma                                                                                                            tyrosine phosphatase activity
                               Protein S100-A10                                                                           S100A10                             Calcium ion binding
                               Protein S100-A8                                                                              S100A8                                               "
                               SH3 domain-binding glutamic acid-rich-like protein                 SH3BGRL                                     Unknown
                               Cell differentiation                                                                                                                                        
                               Keratinocyte proline-rich protein                                                     KPRP                                         Unknown
                               Adipogenesis regulatory factor                                                       ADIRF                                Cell differentiation
                               Cell growth and/or maintenance                                                                                                                  
                               Actin-related protein 3                                                                    ACTR3                Structural constitutent of cytoskeleton
                               Actin-related protein 2/3 complex subunit 5                                 ARPC5                        Cytoskeletal binding protein
                               Isoform 2 of Adenylyl cyclase-associated protein 1                       CAP1                                         Unknown
                               F-actin-capping protein subunit alpha-2                                       CAPZA2               Structural constitutent of cytoskeleton
                               Isoform 2 of Clathrin heavy chain 1                                                CLTC                          Structural molecule activity
                               Isoform DPII of Desmoplakin                                                           DSP                   Structural constitutent of cytoskeleton
                               Isoform 5 of Filamin-B                                                                    FLNB                          Cytoskeletal binding protein
                               Isoform 2 of Kinectin                                                                       KTN1                       Cytoskeletal anchoring activity
                               Isoform 6 of Microtubule-associated protein 4                              MAP4                         Cytoskeletal protein binding
                               Myosin-10                                                                                        MYH10                         Structural molecule activity
                               Isoform 4 of Myosin-11                                                                  MYH11                                               "
                               Myosin-9                                                                                           MYH9                                               "
                               Isoform 2 of Unconventional myosin-Ic                                        MYO1C                                   Motor activity
                               Unconventional myosin-Ie                                                              MYO1E                                              "
                               Profilin-1                                                                                            PFN1                          Cytoskeletal binding protein
                               Isoform 3 of Spectrin beta chain, erythrocytic                                SPTB                          Structural molecule activity
                               Utrophin                                                                                            UTRN                       Cytoskeletal anchoring activity
                               Cholesterol metabolic process                                                                                                                     
                               Erlin-1                                                                                              ERLIN1                               Cholesterol binding
                               Cytoskeleton organization and biogenesis                                                                                                   
                               Ras GTPase-activating-like protein IQGAP1                                IQGAP1                          GTPase activator activity
                               Vasodilator-stimulated phosphoprotein                                            VASP                          Cytoskeletal protein binding
                               Fatty acid beta-oxidtion                                                                                                                                
                               Isoform 2 of Enoyl-CoA delta isomerase 1, mitochondrial             ECI1                       Isomerase and hydratas activity
                               Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial           ECH1                                  Isomerase activity
                               Immune response                                                                                                                                          
                               Membrane primary amine oxidase                                                  AOC3                      Cell adhesion molecule activity
                               C4b-binding protein alpha chain                                                     C4BPA                               Complement activity
                               D-dopachrome decarboxylase                                                           DDT                                   Isomerase activity
                               Ig gamma-1 chain C region                                                             IGHG1                                   Antigen binding
                               Ig gamma-2 chain C region                                                             IGHG2                                               "
                               Ig gamma-4 chain C region                                                             IGHG4                                               "
                               Ig heavy chain V-I region V35                                                      IGHV1-2                                              "
                               Ig heavy chain V-III region JON                                                   IGHV3-7                                              "
                               Immunoglobulin lambda-like polypeptide 5                                   IGLL5                                               "
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Table IX. Continued
CM                         Biological process                                                                         Gene name                             Molecular function
                               Metabolism                                                                                                                                                    
                               Platelet glycoprotein 4                                                                      CD36                                   Receptor activity
                               Metabolism; Energy pathways                                                                                                                     
                               Adenosylhomocysteinase                                                                  AHCY                                 Hydrolase activity
                               Isoform 2 of Cytosolic 10-formyltetrahydrofolate                      ALDH1L1                               Catalytic activity
                               dehydrogenase 
                               Flavin reductase (NADPH)                                                             BLVRB                           Oxidoreductase activity
                               Carbonic anhydrase 1                                                                        CA1                                    Catalytic activity
                               Carbonic anhydrase 2                                                                        CA2                                                  "
                               Catalase                                                                                               CAT                               Oxidoreductase activity
                               Acyl-CoA-binding protein                                                                 DBI                                    Receptor binding
                               Alpha-enolase                                                                                   ENO1                                  Catalytic activity
                               Coagulation factor XIII A chain                                                      F13A1                                Transferase activity
                               Fumarylacetoacetase                                                                          FAH                                   Hydrolase activity
                               Polypeptide N-acetylgalactosaminyltransferase 5                        GALNT5                      Galacotsyltransferase activity
                               Isoform 2 of Lactoylglutathione lyase                                             GLO1                                      Lyase activity
                               Glutaredoxin-1                                                                                  GLRX                             Oxidoreductase activity
                               Aspartate aminotransferase                                                              GOT1                               Transaminase activity
                               Isoform 2 of Glycerol-3-phosphate                                                 GPD1                                  Catalytic activity
                               dehydrogenase [NAD(+)], cytoplasmic
                               Glutathione S-transferase P                                                             GSTP1                      Gluthatione transferase activity
                               Hypoxanthine-guanine phosphoribosyltransferase                         HPRT1                                  Catalytic activity
                               Isocitrate dehydrogenase [NADP] cytoplasmic                               IDH1                                                 "
                               Isoform 4 of L-lactate dehydrogenase A chain                               LDHA                                               "
                               L-lactate dehydrogenase B chain                                                     LDHB                                                "
                               Malate dehydrogenase, cytoplasmic                                               MDH1                                               "
                               Vesicle-fusing ATPase                                                                        NSF                                      ATPase activity
                               Phosphoglycerate mutase 1                                                            PGAM1                                 Catalytic activity
                               6-phosphogluconate dehydrogenase, decarboxylating                     PGD                                                 "
                               Phosphoglycerate kinase 1                                                               PGK1                                                "
                               Purine nucleoside phosphorylase (Fragment)                                    PNP                               Phosphorylase activity
                               Peroxiredoxin-2                                                                               PRDX2                               Peroxidase activity
                               Thioredoxin-dependent peroxide reductase, mitochondrial           PRDX3                                               "
                               Isoform Cytoplasmic+peroxisomal of                                             PRDX5                            Oxidoreductase activity
                               Peroxiredoxin-5, mitochondrial 
                               Peroxiredoxin-6                                                                               PRDX6                                Peroxidase activity
                               Isoform 2 of Glycogen phosphorylase, liver form                         PYGL                              Phosphorylase activity
                               Dihydropteridine reductase                                                              QDPR                                  Catalytic activity
                               Superoxide dismutase [Cu-Zn]                                                        SOD1                        Superoxide dismutase activity
                               Threonine--tRNA ligase, cytoplasmic                                             TARS                                     Ligase activity
                               Thioredoxin                                                                                        TXN                                    Catalytic activity
                               Isoform 2 of UDP-glucose:glycoprotein glucosyltransferase 1       UGGT1                               Transferase activity
                               Isoform 2 of UTP--glucose-1-phosphate uridylyltransferase          UGP2                        Nucleotidyltransferase activity
                               Transitional endoplasmic reticulum ATPase                                    VCP                                     ATPase activity
                               Protein folding; peptide metabolism                                                                                                            
                               Peptidyl-prolyl cis-trans isomerase A                                               PPIA                                   Isomerase activity
                               Protein metabolism                                                                                                                                       
                               Calpain-1 catalytic subunit                                                             CAPN1                          Cystein-peptidase activity
                               T-complex protein 1 subunit theta                                                   CCT8                                  Chaperone activity
                               Cystatin-B                                                                                         CSTB                            Protease inhibitor activity
                               DnaJ homolog subfamily A member 1                                         DNAJA1                        Heat shock protein activity
                               Heat shock 70 kDa protein 1A/1B                                                HSPA1A                               Chaperone activity
                               Heat shock 70 kDa protein 4                                                           HSPA4                                               "
                               Heat shock protein beta-1                                                               HSPB1                                               "
                               Isoform 3 of Leukotriene A-4 hydrolase                                        LTA4H                                 Hydrolase activity
                               Puromycin-sensitive aminopeptidase                                             NPEPPS                           Aminopeptidase activity
                               Peptidyl-prolyl cis-trans isomerase B                                               PPIB                                  Chaperone activity
                               Proteasome subunit alpha type-5                                                    PSMA5                   Ubiquitin-specific protease activity
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Table IX. Continued
CM                         Biological process                                                                         Gene name                             Molecular function
                               Proteasome (Prosome, macropain) subunit,                                   PSMA6                                              "
                               alpha type, 6, isoform CRA_a 
                               Proteasome subunit alpha type-7                                                     PSMA7                                               "
                               Proteasome subunit beta type-1                                                      PSMB1                                               "
                               60S acidic ribosomal protein P1                                                     RPLP1                   Structural constitutent of ribosome
                               40S ribosomal protein S28                                                              RPS28                                               "
                               Isoform 2 of Selenium-binding protein 1                                   SELENBP1                                    Unknown
                               Leukocyte elastase inhibitor                                                        SERPINB1                        Protease inhibitor activity
                               Serpin B12                                                                                   SERPINB12                                           "
                               Serpin B6                                                                                      SERPINB6                                           "
                               Isoform 2 of Ubiquitin-conjugating enzyme E2 L3                     UBE2L3                 Ubiquitin-specific protease activity
                               Isoform 2 of Tryptophan--tRNA ligase, cytoplasmic                     WARS                                    Ligase activity
                               Protein metabolism; Proteolysis and peptidolysis                                                                                       
                               Isoform 3 of Proteasome subunit beta type-5                                PSMB5                   Ubiquitin-specific protease activity
                               Protein metabolism; translation                                                                                                                    
                               Elongation factor 2                                                                            EEF2                         Translation regulatory activity
                               Regulation of cell cycle                                                                                                                                
                               14-3-3 protein zeta/delta                                                                YWHAZ         Receptor signaling complex scaffold activity
                               Regulation of nucleobase, nucleoside,
                               nucleotide and nucleic acid metabolism                                                                                                     
                               Cytoplasmic aconitate hydratase                                                      ACO1                                  Isomerase activity
                               Breast cancer type 2 susceptibility protein                                     BRCA2                     Transcription regulatory activity
                               DNA damage-binding protein 1                                                       DDB1                                 DNA repair protein
                               Heterogeneous nuclear ribonucleoprotein A1                             HNRNPA1                                  RNA binding
                               Nucleolin                                                                                            NCL                                       RNA binding
                               Signal transduction; Vesicle-mediated transport                                                                                         
                               Intersectin 1 long form variant 4                                                     ITSN1            Receptor signaling complex scaffold activity
                               Synaptic vesicle transport                                                                                                                             
                               Isoform 2 of Protein piccolo                                                            PCLO                  Structural constitutent of cytoskeleton
                               Transport                                                                                                                                                        
                               Early endosome antigen 1                                                                EEA1                    Auxiliary transport protein activity
                               Ferritin light chain                                                                              FTL                                      Storage protein
                               BTB/POZ domain-containing protein KCTD12                           KCTD12                              Ion channel activity
                               Ribosome-binding protein 1                                                            RRBP1                     Transmembrane receptor activity
                               Non-specific lipid-transfer protein                                                   SCP2                    Auxiliary transport protein activity
                               Solute carrier family 2, facilitated glucose                                   SLC2A1                                              "
                               transporter member 1 (Fragment) 
                               Band 3 anion transport protein                                                      SLC4A1                                              "
                               Isoform 2 of Syntaxin-7                                                                   STX7                                    Binding protein
                               Synaptotagmin-like protein 5                                                          SYTL5                                Transporter activity
                               General vesicular transport factor p115 (Fragment)                       USO1                                 Transporter activity
                               Unknown                                                                                                                                                       
                               Barrier-to-autointegration factor                                                     BANF1                                     DNA binding
                               Dynein light chain roadblock-type 2                                            DYNLRB2                                    Unknown
                               SH3 domain-binding glutamic acid-rich-like protein 2             SH3BGRL2                                           "
T2                           Regulation of nucleobase, nucleoside,
                               nucleotide and nucleic acid metabolism                                                                                                     
                               Isoform A2 of Heterogeneous nuclear                                      HNRNPA2B1                    Transcription factor binding
                               ribonucleoproteins A2/B1 
T2 and T3              Aldheyde metabolism                                                                                                                                   
                               Retinal dehydrogenase 1                                                               ALDH1A1                  Aldheyde dehydrogenase activity
                               Cell communication; Signal transduction                                                                                                    
                               14-3-3 protein gamma                                                                    YWHAG         Receptor signaling complex scaffold activity
                               Cell growth and/or maintenance                                                                                                                  
                               Actin, cytoplasmic 1                                                                         ACTB                 Structural constitutent of cytoskeleton
                               Desmin                                                                                                DES                                                 "
                               Spectrin alpha chain, non-erythrocytic 1                                      SPTAN1                                              "
                               Spectrin beta chain, non-erythrocytic 1                                        SPTBN1                                              "
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Table IX. Continued
CM                         Biological process                                                                         Gene name                             Molecular function
                               Talin-1                                                                                                TLN1                          Cytoskeletal protein binding
                               Isoform 1 of Vinculin                                                                        VCL                                                 "
                               Immune response                                                                                                                                          
                               Ig alpha-1 chain C region                                                                IGHA1                                   Antigen binding
                               Ig alpha-2 chain C region                                                                IGHA2                                               "
                               Ig mu heavy chain disease protein                                                  IGHM                                                "
                               Metabolism; Energy pathways                                                                                                                     
                               Aldo-keto reductase family 1 member C3                                    AKR1C3                                Catalytic activity
                               Aldehyde dehydrogenase, mitochondrial                                       ALDH2                                              "
                               Isoform 2 of Triosephosphate isomerase                                          TPI1                                   Isomerase activity
                               Protein metabolism                                                                                                                                       
                               Proteasome subunit alpha type-1                                                    PSMA1                                Peptidase activity
                               Proteasome subunit beta type-4                                                      PSMB4                   Ubiquitin-specific protease activity
                               Transport                                                                                                                                                        
                               B-cell receptor-associated protein 31                                            BCAP31                              Transporter activity
                               Hemoglobin subunit delta                                                                 HBD                                                 "
                               Unknown                                                                                                                                                       
                               Hornerin                                                                                            HRNR                                        Unknown
T3 y BPH               Cell adhesion; Signal transduction                                                                                                              
                               Ras suppressor protein 1                                                                  RSU1                                         Unknown
                               Junction plakoglobin                                                                          JUP                         Cell adhesion molecule activity
                               Protein S100-A9                                                                              S100A9                               Calcium ion binding
                               Cell growth and/or maintenance                                                                                                                  
                               Isoform 2 of Alpha-actinin-1                                                          ACTN1                        Cytoskeletal protein binding
                               Alpha-actinin-4                                                                                 ACTN4                Structural constitutent of cytoskeleton
                               Tubulin alpha-1A chain                                                                 TUBA1A                                             "
                               Immune response                                                                                                                                          
                               Ig gamma-3 chain C region                                                             IGHG3                                   Antigen binding
                               Ig kappa chain C region                                                                   IGKC                                                "
                               Ig lambda-2 chain C regions                                                           IGLC2                                                "
                               Metabolism; Energy pathways                                                                                                                     
                               Phosphoglucomutase-1                                                                     PGM1                                  Catalytic activity
                               Peroxiredoxin-1                                                                                PRDX1                                Peroxidase activity
                               Muscle contraction                                                                                                                                       
                               Neuroblast differentiation-associated protein AHNAK                AHNAK                                  Protein binding
                               Protein metabolism                                                                                                                                       
                               10 kDa heat shock protein, mitochondrial                                     HSPE1                          Heat shock protein activity
                               Regulation of nucleobase, nucleoside,
                               nucleotide and nucleic acid metabolism                                                                                                     
                               Ribonuclease inhibitor                                                                      RNH1                       Translation regulatory activity
                               Unknown                                                                                                                                                       
                               Transgelin-2                                                                                    TAGLN2                                       Unknown
T3, T2 and BPH    Cell communication; Signal transduction                                                                                                    
                               Fatty acid-binding protein, adipocyte                                             FABP4                                 Chaperone activity
                               Cell growth and/or maintenance                                                                                                                  
                               Isoform 2 of Collagen alpha-1(XIV) chain                                  COL14A1          Extracellular matrix structural constitutent
                               Isoform 2 of Filamin-A                                                                    FLNA                       Cytoskeletal anchoring activity
                               Isoform 2 of Tropomyosin alpha-4 chain                                        TPM4                 Structural constitutent of cytoskeleton
                               Vimentin                                                                                             VIM                                                 "
                               Immune response                                                                                                                                          
                               Galectin-1                                                                                       LGALS1                                 Receptor binding
                               Metabolism; Energy pathways                                                                                                                     
                               N(G),N(G)-dimethylarginine dimethylaminohydrolase                DDAH2                                Hydrolase activity
                               2 (Fragment)
                               Glucose-6-phosphate isomerase                                                         GPI                                   Isomerase activity
                               Regulation of nucleobase, nucleoside,
                               nucleotide and nucleic acid metabolism                                                                                                     
                               Histone H4                                                                                    HIST1H4A                                  DNA binding
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Table X. Comparison of secretomes from previous literature.
Previous proteomic                                         Human adipose                                 BMI            # Proteins      # Overlap proteins      # Overlap proteins
literature (# reference)                                            source                                                              Literature         CMs-T (n=573)         CM-BPH (n=52)
Lapeire L. et al. (17)                          Breast associated/breast cancer                   no data               668                  274 (48%)                     45 (87%)
Alvarez-Llamas et al. (18)         Visceral non-carcinogenic gynecological             19-31                 259                  139 (24%)                     22 (42%)
Lher S. et al. (85)                        Subcutaneous/adipocyte/healthy female           26.2±0.6              347                  164 (29%)                     24 (46%)
Zhong et al. (65)                          Subcutaneous/adipocyte/healthy female             36±7.6                420                  178 (31%)                     26 (50%)
Zvonic et al. (86)                                   Subcutaneous/ASC/female                      25.7±3.8              101                    41 (7%)                         6 (12%)
Delany et al. (87)                      Subcutaneous/ASC/healthy male & female        30.4±7.1              172                    68 (12%)                       6 (12%)
BMI: Body mass index kg/m2.
Comparison with previous literature. It was of interest to make
a comparison of our results with previously available human
adipose proteomic/secretome literature (Table X). The
comparison of our CMs-T (stages T2 and T3, n=573) with
proteins detected in adipose tissue associated with breast cancer
presented byLapeire et al. (17) revealed 274 superimposed
proteins (48%) while the comparison with CM-BPH (n=52)
revealed 48 proteins (92%). Furthermore, comparison with
proteins detected in visceral adipose tissue explants of non-
carcinogenic gynecologic disorders, as described by Alvarez-
Llamas et al. (18), revealed 139 overlapped proteins with our
CMs-T (24%) and 22 overlapped proteins (42%) with our CM-
BPH secretome. A comparison with proteins secreted by
adipocytes from subcutaneous adipose tissue of women
undergone elective plastic surgery (82) or panniculectomy
surgery (65) showed 29-31% overlapping proteins with our
CMs-T and 46% to 50% overlapping proteins with CM-BPH,
respectively. A minor number of overlapping proteins was
found when comparing adipose stem cells (ASC) from
lipoaspirates of subcutaneous adipose tissue of male and/or
female undergone plastic surgery (83, 84), 7% to 12% for
CMs-T and 12% for CM-BPH. Thus, unlike CMs-T, a major
percentage of proteins from CM-BPH were common to adipose
tissue depots. This result confirmed that PPAT secretome
derived from patients with tumour have a unique secretion
profile with many proteins not previously identified in adipose
tissue. A simultaneous comparison with all the data sets
described above, led us to create a list of specific proteins.
Some of the detected proteins belonged to the serpin family.
Among those, and not yet described in the context of adipocyte
biology, SERPINA4, SERPINB12, SERPINB4, SERPIND1
were found. They are the largest and most broadly distributed
superfamily of protease inhibitors; they have multiple functions
including coagulation, host defence, and ischemia protection
(85). Eight serpins were present in previously studied adipocyte
proteomes and secretomes, the majority serving as extracellular
protease inhibitors (84). In a cancer context, it was reported
that circulating levels of kallistatin (SERPINA4) are markedly
reduced in patients with PCa. Kallistatin’s active site is
essential for inhibiting tissue kallikrein’s activity and
modulating the synthesis of microRNAs, (miR-34a, miR-21
and miR-203) among other functions. Also, kallistatin’s
heparin-binding site is crucial for antagonizing the signalling
pathways of vascular endothelial growth factor, tumour
necrosis factor-α, wnt, transforming growth factor-β and
epidermal growth factor (86). Another protein family detected
in CM-T3 was SLC transporters (SLC2A1, SLC2A14,
SLC4A1 and SLC9A3R). Recently, SLC transporters are
receiving increasing attention in relation to cancer. Several
transporters for essential nutrients are up-regulated in cancer
and serve as tumour promoters (87). Several proteins related
to regulation of complement activation (IGLV6-57, IGHV1-2,
IGHV3-23, IGHV3-53, IGHV3-7, IGKV1-5, IGKV1D-12,
IGLV3-25) were found. TGF-beta activated kinase 1 and
MAP3K7 (MAP3K7/TAK1) binding protein 3 (TAB3,
serine/threonine kinase) act as essential components of the
MAP kinase signal transduction pathway and play an important
role in the cascades of cellular responses to changes in the
environment. Their inhibition decreases lipid accumulation in
mesenchymal stem cells (MSCs), induced to differentiate into
adipocytes and inhibit adipogenesis of 3T3-L1 preadipocytes
(88). TAB3 was reported as an oncogene and a biomarker for
ovarian cancer (89). All these results reinforce the idea that
each adipose deposit has its own profile and is specific for
disease and gender.
In a subsequent comparison with existing literature, related
to PCa biomarkers candidates, several proteins were detected
in our study. Among them: complement C5 (C5), complement
factor B (CFB), complement component C9 (C9),
ceruloplasmin (CP), inter-alpha-trypsin inhibitor heavy chain
H4 (ITIH4), alpha-1-antichymotrypsin (SERPINA3) and
plasma protease C1 inhibitor (SERPING1) were detect in CM-
T3; antithrombin-II (SERPINC1) and leucine-rich alpha-2-
glycoprotein (LRG1) were detected in CMs-T. These proteins
were found increased in progressing, relative to non-
progressing PCa (90). Furthermore, afamin (AFM), vitronectin
(VTN) and lumican (LUM) was detected in CM-T3; beta-2-
glycoprotein 1 (APOH) was detected in CMs-T while alpha-
2-HS-glycoprotein (AHSG) was detected only in CM-T2.
Alpha-2-macroglobulin (A2M) was detected in the three CMs.
Rheman et al. (90) found these last proteins increased in non-
progressing cancer relative to BPH in serum samples. Vitamin
D-binding protein (GC), zinc-alpha-2-glycoprotein (AZGP1),
elongation factor 1-alpha 1 (EEF1A1) and hemopexin (HPX)
were detected in CM-T3 by us and were found increased in
metastatic versus progressing cancer by the same authors.
Glycoproteins associated to cancer could also be detected in
CM-T3 secretome like periostin (POSTN), versican core
protein (VCAN), fibrillin-1 (FBN1) and laminin subunit beta-
2 (LAMB2) which was also found in urine, while zinc-alpha-
2-glycoprotein (AZGP1) was found in urine and serum of
aggressive PCa in a glycoproteomic work (91).
Relative protein quantification. The emPAI method for protein
quantification was used since it provides an absolute
abundance value that enables comparison of datasets. Relative
emPAI (%) were calculated for proteins. Applying this
method, the abundance of shared proteins was compared and
selected those with a two-fold change in emPAI (%) between
the proteins of the three CMs (Figure 5E), CM-T2 relative to
CM-T3 proteins (Figure 5F) and CM-T3 relative to CM-BPH
proteins (Figure 5G). Hemoglobin subunit alpha, a typical
serum protein, appeared with high emPAI (%) in all CMs
(Figure 5E). Comparison of the three CMs indicated that fatty
acid binding protein 4 was more abundant (19-fold) in CM-
T3 relative to CM-T2 and 4-fold relative to CM-BPH while
histone H4 was more abundant (5-fold) in CM-T2 relative to
CM-T3 and 8-fold to CM-BPH. Immunoglobulin kappa
constant fraction was more abundant (2-fold) in CM-T3
relative to CM-T2. Antithrombin-III (SERPINC1),
triosephosphate isomerase (TPI1) and vinculin (VCL) were
more abundant (3-fold) in CM-T3 relative to CM-T2. Alpha-
1-acid glycoprotein was more abundant (5-fold) in CM-T2
relative to CM-T3.
SERPINC1, a protease with inhibitory activity, as well
as angiogenesis and tumour growth inhibitor, was found
increased in visceral adipose tissue of pre-obese diabetics
relative to non-diabetic patients (92) and also found
increased in healthy obese individuals (93). Its expression
was increased in Gleason grade group 1 to 3, being higher
in group 3 but was gradually lost in tumours with higher
Gleason grade (94). The TPI1 gene was found up-regulated
in the conditioned medium of BPH-1 and LNCaP cells (95)
and down-regulated during differentiation of brown mouse
preadipocytes (96). The rounding and aggregation of the
3T3 preadipocytes, while differentiating into adipocytes
are accompanied with changes in cytoskeletal-extracellular
matrix components, with changes in shape leading to a
decrease in the positive vinculin focal adhesion (97). VCL,
identified by quantitative proteomics, was highly
expressed in PCa cells with high migration potential like
PC3 cells (98).
Discussion 
Proteins secreted by a particular cell type play important roles
in regulation of many physiological processes via
paracrine/autocrine mechanisms and they are of increasing
interest as potential biomarkers and therapeutic targets.
Knowledge of the proteins released by cells in conditioned
media in vitro as well as their biological functions and related
pathways will allow a better understanding of pathological
conditions and mechanisms in vivo. It is well known that there
is a bi-directional crosstalk between adipose tissue and tumour
cells. Adipose tissue modulates the tumour microenvironment
by promoting angiogenesis, affecting immune cells and
altering metabolism to support growth and survival of
metastatic cancer cells. On the other hand, tumour cells would
induce adipose tissue to secrete several molecules that would
stimulate adhesion, migration, and invasion, and would also
induce adipocyte cells to dedifferentiate into pre-adipocytes
and, then, reprogram them into cancer-associated adipocytes
that would stimulate cancer progression. 
This study showed that the quantity, number and variety of
proteins detected in CMs-T was higher than in CM-BPH; also,
multiple unique proteins were detected under disease progress.
These findings indicate the molecular diversity that exist in the
adipose tissue of cancer patients with respect to adipose tissue
of patients with benign disease and showed that a more active
heterotypic crosstalk could promote tumourigenicity, as we and
others have previously reported (6, 7, 10, 81). 
Although PPAT collected for this study is not in direct
contact with tumour mass, the absolute absence of tumour
cells in PPAT of patients in T3 stage cannot be ruled out. We
can speculate that if there were tumour cells, their quantity
would be low and probably the sensitivity of MS would not
allow for detection of the proteins released by these cells.
Moreover, after collecting the CMs, the PPAT tissues were
subjected to collagenase treatment, for further culture and
growth of stromal vascular fraction up to passage 4 (p4)
obtaining an adipose stem cell (ASC) culture, that under
microscopic observation did not show epithelial cell
morphology (data not shown). Several proteins, which were
not previously associated with adipose tissue, were also found
in this secretome analysis. Many of them were reported in the
secretome of PCa cells, or in co-cultures of tumour cells of
different origins with the associated stromal cells. Although
the presence of tumour cells in PPAT from patients in T3
stage cannot be ruled out, an "ex vivo heterotypic secretome"
could be studied and a protein profile approximate to that
present in vivo would be observed in CMs. It is important to
consider the possible presence of cell-derived vesicles
(exosomes) in CMs. Exosomes were the most represented
cellular component in the three CMs. Exosomes transport
molecular signals between cells and their protein content
profile changes in response to the microenvironment. The
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proteins found in the PPAT secretome of patients with PCa
could derive from the tumour and packaged in exosomes,
because some proteins have not been reported in the adipose
tissue. Using ex vivo cultures and MS, it was possible to
identify several proteins that are intimately involved in the
biology of adipose tissue and, also, several potential
molecules secreted by PPAT which could be associated with
pro-tumourigenic biological processes. Finally, proteins that
had not been previously documented in adipose tissue and
appeared secreted in PPAT-CMs during the course of the
disease were identified. They must be subjected to functional
evaluation and there is need for further validation using a
larger cohort of patients. Also, many proteins have not been
described in the context of adipocyte biology and their exact
function needs to be elucidated. Further examination of their
expression profiles will provide mechanistic insights into
adipose tissue physiology and pathology.
Our study has certain limitations. Proteins found do not
derive only from adipose cells, but also from other cell types
including inflammatory cells and blood vessels and, thus,
cannot be assigned to a specific cell type. Some proteins
could also be originated from damaged cells despite the fact
that the tissue was carefully treated and, also, proteomic
screenings cannot identify all proteins in a solution. The
small number of samples used in this study reduces the
power of the analysis.
This research represents a further step in the knowledge
of the PPAT microenvironment, and provides data on
differentially expressed proteins and signalling pathways,
and strongly suggests a role for the adipose depots depending
on its anatomical location and the disease. A deeper
knowledge of these mechanisms will reveal several potential
targets for prostate cancer and/or benign disease treatment.
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